ONCOLOGY MSN SYN.

πŸ“šπŸ©Ί Cancer (Malignancy)

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. If not detected and treated early, it can lead to invasion of surrounding tissues and distant metastasis, resulting in significant morbidity and mortality.

βœ… β€œCancer is defined as the abnormal and uncontrolled proliferation of cells, which can invade nearby tissues and spread to distant organs through the blood or lymphatic system.”


πŸ“– II. Types of Cancer

TypeDescription
CarcinomaCancer of epithelial cells (e.g., breast, lung, colon).
SarcomaCancer of connective tissues (e.g., bone, muscle).
LeukemiaCancer of blood-forming tissues (bone marrow).
LymphomaCancer of lymphatic system (e.g., Hodgkin’s, Non-Hodgkin’s).
MelanomaCancer of melanocytes (skin cancer).
MyelomaCancer of plasma cells (bone marrow).

πŸ“– III. Causes / Risk Factors

  • Genetic Factors: Family history of cancer, genetic mutations (BRCA1, BRCA2).
  • Environmental Factors: Radiation exposure, UV light.
  • Lifestyle Factors: Smoking, alcohol consumption, unhealthy diet, obesity.
  • Occupational Exposures: Asbestos, benzene, industrial chemicals.
  • Infections: HPV (cervical cancer), Hepatitis B/C (liver cancer), H. pylori (gastric cancer).
  • Hormonal Imbalances and Chronic Inflammation.

πŸ“– V. Clinical Manifestations (General Signs & Symptoms)

  • Unexplained weight loss and loss of appetite.
  • Persistent fatigue and weakness.
  • Unusual bleeding or discharge.
  • Lump or mass in any part of the body.
  • Persistent cough, hoarseness, or difficulty swallowing.
  • Changes in bowel or bladder habits.
  • Non-healing sores or ulcers.
  • Skin changes: New moles or changes in existing moles.

⚠️ Mnemonic for Cancer Warning Signs:
C A U T I O N
C – Change in bowel or bladder habits.
A – A sore that does not heal.
U – Unusual bleeding or discharge.
T – Thickening or lump in breast or elsewhere.
I – Indigestion or difficulty swallowing.
O – Obvious change in a wart or mole.
N – Nagging cough or hoarseness.

πŸ“– VI. Diagnostic Evaluation

TestPurpose
BiopsyConfirms cancer diagnosis by examining tissue.
Tumor MarkersCEA, CA-125, PSA (used for monitoring).
Imaging StudiesX-ray, CT Scan, MRI, PET Scan to identify tumor location and metastasis.
Blood TestsAssess overall health and organ function.
Endoscopy/ColonoscopyFor GI tract cancers.
MammographyBreast cancer screening.

πŸ“šπŸ©Ί Tumor Markers

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Tumor Markers are biological substances produced by cancer cells or by normal cells in response to cancer. These markers are found in blood, urine, body fluids, or tissues and help in diagnosing, monitoring, and predicting prognosis of cancer.

βœ… β€œTumor markers are specific proteins, hormones, enzymes, or antigens associated with malignancies, used primarily for cancer detection and monitoring treatment response.”


πŸ“– II. Types of Tumor Markers and Their Clinical Significance

Tumor MarkerAssociated CancersNormal Range
AFP (Alpha-Fetoprotein)Liver cancer (Hepatocellular carcinoma), Testicular cancer<10 ng/mL
CEA (Carcinoembryonic Antigen)Colorectal, Lung, Breast, Pancreatic cancers<3 ng/mL (non-smoker), <5 ng/mL (smoker)
CA-125Ovarian cancer<35 U/mL
CA-19-9Pancreatic and Biliary tract cancers<37 U/mL
PSA (Prostate-Specific Antigen)Prostate cancer<4 ng/mL
CA-15-3Breast cancer<30 U/mL
Beta-hCG (Human Chorionic Gonadotropin)Choriocarcinoma, Testicular cancer<5 mIU/mL
CalcitoninMedullary Thyroid Cancer<10 pg/mL
LDH (Lactate Dehydrogenase)Lymphomas, Leukemia, Testicular cancer<250 U/L
ThyroglobulinThyroid cancers<55 ng/mL

πŸ“– III. Uses of Tumor Markers

  • Screening and Early Detection of Cancer.
  • Diagnosis Confirmation (with imaging and biopsy).
  • Monitoring Treatment Response (Chemotherapy/Radiotherapy).
  • Detecting Cancer Recurrence.
  • Prognostic Evaluation (predicting survival rates).

πŸ“– IV. Limitations of Tumor Markers

  • Not always specific to cancer; may be elevated in benign conditions.
  • Not suitable as standalone diagnostic toolsβ€”must be combined with clinical evaluation and imaging.
  • False positives and false negatives can occur.

πŸ“– V. Nurse’s Role in Tumor Marker Testing

  • Educate the patient about the purpose of the test.
  • Ensure correct specimen collection (blood/urine).
  • Monitor the patient for emotional distress related to cancer diagnosis.
  • Assist the patient with regular follow-ups and reporting results to physicians.
  • Provide psychological support, especially if results suggest malignancy.


πŸ“š Golden One-Liners for Quick Revision:

  • CA-125 is primarily used for detecting ovarian cancer.
  • PSA is the most widely used tumor marker for prostate cancer screening.
  • AFP is associated with liver and testicular cancers.
  • Tumor markers cannot replace biopsy for definitive diagnosis.
  • Beta-hCG is elevated in choriocarcinoma and testicular cancers.


βœ… Top 5 MCQs for Practice

Q1. Which tumor marker is primarily used for ovarian cancer detection?
πŸ…°οΈ CA-19-9
βœ… πŸ…±οΈ CA-125
πŸ…²οΈ AFP
πŸ…³οΈ PSA


Q2. What is the normal reference value of PSA in a healthy adult male?
πŸ…°οΈ <2 ng/mL
πŸ…±οΈ <3 ng/mL
βœ… πŸ…²οΈ <4 ng/mL
πŸ…³οΈ <5 ng/mL


Q3. Beta-hCG is commonly elevated in which malignancy?
πŸ…°οΈ Breast cancer
πŸ…±οΈ Colorectal cancer
βœ… πŸ…²οΈ Testicular cancer
πŸ…³οΈ Lung cancer


Q4. Which tumor marker is associated with pancreatic cancer?
πŸ…°οΈ CA-125
πŸ…±οΈ CA-15-3
βœ… πŸ…²οΈ CA-19-9
πŸ…³οΈ CEA


Q5. Which tumor marker is useful in monitoring medullary thyroid cancer?
πŸ…°οΈ Thyroglobulin
πŸ…±οΈ CEA
πŸ…²οΈ CA-19-9
βœ… πŸ…³οΈ Calcitonin

πŸ“šπŸ—‚οΈ Classification of Cancer: Stage, Grade & TNM

πŸ“˜ Highly Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Medical-Surgical Nursing Exams


πŸ”° I. Definition:

Cancer classification includes evaluating the extent (stage) and appearance/aggressiveness (grade) of cancer.
This helps determine treatment, prognosis, and survival outcomes.
The TNM system is a universal method for describing tumor status in solid cancers.

β€œCancer classification involves assigning a stage and grade to describe how far cancer has spread and how abnormal the cells appear microscopically.”


πŸ“– II. Cancer Staging (Extent of Spread):

StageDescription
Stage 0Carcinoma in situ (confined to site of origin)
Stage ISmall, localized tumor without lymph node involvement
Stage IILarger tumor, may involve nearby lymph nodes
Stage IIILocally advanced tumor with extensive lymph node involvement
Stage IVDistant metastasis to other organs (e.g., liver, lungs, brain)

πŸ“– III. Cancer Grading (Cell Appearance & Aggressiveness):

GradeDescription
Grade 1 (Low grade)Well-differentiated; cells look like normal cells; slow-growing
Grade 2 (Intermediate)Moderately differentiated; moderate growth rate
Grade 3 (High grade)Poorly differentiated; abnormal cells, aggressive behavior
Grade 4 (Anaplastic)Undifferentiated cells; very aggressive, worst prognosis

πŸ“– IV. TNM Classification System (Solid Tumors):

ComponentMeaning
T (Tumor)Size and extent of the primary tumor (T0–T4)
N (Nodes)Regional lymph node involvement (N0–N3)
M (Metastasis)Distant metastasis present or absent (M0/M1)

Example:

T2N1M0 β†’ Moderate-sized tumor (T2), lymph node involvement (N1), no distant metastasis (M0)


πŸ“– V. Differences Between Stage, Grade & TNM:

FeatureStageGradeTNM
What it describesExtent of spreadAppearance/aggressivenessTumor size, node & metastasis
Based onClinical, imaging, pathologyMicroscopic histologyDetailed pathology & imaging
PurposeTreatment planningPredicts behaviorUniversal staging format

πŸ“– VI. Diagnostic Evaluation:

  • Biopsy & Histopathology: Confirms cancer, assigns grade
  • Imaging: X-ray, CT, MRI, PET to determine stage and metastasis
  • Surgical staging: May involve lymph node sampling
  • Molecular testing: For precision staging in some cancers
  • Tumor markers: May support staging in some cancers (e.g., PSA, CA-125)

πŸ“– VII. Management Based on Classification:

Stage/GradeTypical Treatment
Early stage, low gradeSurgery or local radiation
Moderate stage/gradeCombined chemo, surgery, and/or radiation
Advanced stage or high gradeAggressive chemo, targeted or palliative care
Metastatic (Stage IV)Systemic therapy + supportive care

πŸ“– VIII. Nursing Responsibilities:

  • Educate patients about meaning of stage/grade and treatment options
  • Support during diagnostic tests (biopsy, scans)
  • Provide psychological support post-diagnosis
  • Monitor for treatment response and side effects
  • Educate on prognosis and importance of regular follow-up
  • Reinforce screening and early detection for family members at risk

πŸ“š Golden One-Liners for Quick Revision:

  • Staging = how far the cancer has spread
  • Grading = how abnormal the cancer cells look
  • Stage 0 = carcinoma in situ
  • Grade 4 = anaplastic cells, most aggressive
  • TNM is the global system for solid tumor staging
  • T4N3M1 = advanced cancer with large tumor, multiple nodes, and metastasis

βœ… Top 5 MCQs for Practice:

Q1. What does Grade 1 cancer indicate?
πŸ…°οΈ Poorly differentiated cells
βœ… πŸ…±οΈ Well-differentiated cells
πŸ…²οΈ Very aggressive tumor
πŸ…³οΈ Anaplastic cells


Q2. In the TNM classification, β€˜N1’ refers to:
πŸ…°οΈ Large tumor
βœ… πŸ…±οΈ Regional lymph node involvement
πŸ…²οΈ Distant metastasis
πŸ…³οΈ Normal cell appearance


Q3. Which cancer stage indicates metastasis to distant organs?
πŸ…°οΈ Stage I
πŸ…±οΈ Stage II
πŸ…²οΈ Stage III
βœ… πŸ…³οΈ Stage IV


Q4. Grading of cancer is based on:
πŸ…°οΈ Tumor size
πŸ…±οΈ Patient age
βœ… πŸ…²οΈ Cellular differentiation
πŸ…³οΈ Hormonal status


Q5. Which is the most widely accepted cancer staging system for solid tumors?
πŸ…°οΈ WHO system
πŸ…±οΈ Grading system
βœ… πŸ…²οΈ TNM system
πŸ…³οΈ ABC system

πŸ“šπŸ’‰ Chemotherapy

πŸ“˜ Highly Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Medical-Surgical Nursing Exams


πŸ”° I. Definition:

Chemotherapy is the use of cytotoxic drugs to kill or stop the growth of cancer cells.
It may be used alone or in combination with other therapies (surgery, radiotherapy, immunotherapy) depending on the type and stage of cancer.

“Chemotherapy refers to systemic treatment that targets rapidly dividing cells, aiming to cure, control, or palliate cancer.”


πŸ“– II. Classification / Types:

Type of ChemotherapyPurpose
CurativeTo destroy all cancer cells and achieve cure (e.g., leukemia)
AdjuvantGiven after surgery to eliminate residual cancer cells
NeoadjuvantGiven before surgery to shrink tumors
PalliativeTo relieve symptoms and improve quality of life in advanced cancer
Combination chemotherapyUses multiple drugs to enhance effectiveness and prevent resistance

πŸ“– III. Causes / Indications:

  • Solid tumors: Breast, lung, colorectal, ovarian cancers
  • Hematologic cancers: Leukemia, lymphoma, multiple myeloma
  • Metastatic cancers
  • As part of conditioning for bone marrow transplantation
  • Used to prevent recurrence in high-risk cases

πŸ“– IV. Pathophysiology (In Brief):

  1. Chemotherapy drugs target rapidly dividing cells.
  2. Cancer cells are killed through interference in DNA synthesis or cell division.
  3. Normal fast-growing cells (e.g., GI mucosa, hair, bone marrow) are also affected β†’ leads to side effects.

πŸ“– V. Clinical Manifestations (Side Effects):

  • Bone marrow suppression: Anemia, leukopenia, thrombocytopenia
  • GI symptoms: Nausea, vomiting, diarrhea, mucositis
  • Alopecia (hair loss)
  • Fatigue and weakness
  • Immunosuppression β†’ infections
  • Neuropathy (tingling, numbness)
  • Skin changes, nail discoloration
  • Organ toxicity: Cardiac, renal, hepatic

πŸ“– VI. Diagnostic Evaluation (Before and During Therapy):

  • CBC: WBC, Hb, Platelets
  • Renal function: Serum creatinine, BUN
  • Liver function tests (LFTs)
  • ECG/Echo: For cardiotoxic drugs (e.g., doxorubicin)
  • Tumor markers (as per cancer type)
  • Infection screening: Blood/urine cultures if febrile

πŸ“– VII. Management:

🟒 1. Drug Administration:

  • Routes: IV (common), oral, IM, SC, intrathecal
  • Given in cycles (e.g., every 3 weeks)
  • Doses adjusted based on body surface area (BSA) and organ function

🟒 2. Supportive Measures:

  • Antiemetics: Ondansetron, dexamethasone
  • Growth factors: G-CSF for neutropenia
  • Hydration and diuretics for renal protection
  • Blood transfusions if needed
  • Protective isolation for neutropenic patients

πŸ“– VIII. Nursing Responsibilities:

  • Verify drug orders, dosages, and route carefully
  • Maintain strict IV line care and monitor for extravasation
  • Assess for and manage side effects (N/V, mucositis, fatigue)
  • Monitor CBC, renal and liver function tests regularly
  • Implement neutropenic precautions
  • Educate patients on:
    • Hygiene and oral care
    • Avoiding crowds and infection sources
    • Reporting signs of infection or bleeding immediately
    • Coping with hair loss and body image changes

πŸ“š Golden One-Liners for Quick Revision:

  • Chemotherapy targets rapidly dividing cancer cells
  • Side effects occur due to damage to normal dividing cells
  • Bone marrow suppression is the most critical side effect
  • Antiemetics and growth factors help manage toxicity
  • Strict aseptic precautions are essential during neutropenia

βœ… Top 5 MCQs for Practice:

Q1. What is the most serious complication of chemotherapy?
πŸ…°οΈ Alopecia
πŸ…±οΈ Vomiting
βœ… πŸ…²οΈ Bone marrow suppression
πŸ…³οΈ Skin rash


Q2. Neutropenia from chemotherapy increases the risk of:
πŸ…°οΈ Hypertension
πŸ…±οΈ Hair loss
βœ… πŸ…²οΈ Infection
πŸ…³οΈ Constipation


Q3. Which route is most commonly used for chemotherapy?
πŸ…°οΈ Oral
πŸ…±οΈ Intramuscular
βœ… πŸ…²οΈ Intravenous
πŸ…³οΈ Subcutaneous


Q4. A commonly used antiemetic in chemotherapy is:
πŸ…°οΈ Ibuprofen
πŸ…±οΈ Omeprazole
βœ… πŸ…²οΈ Ondansetron
πŸ…³οΈ Paracetamol


Q5. Before administering chemotherapy, which test is essential?
πŸ…°οΈ Lipid profile
βœ… πŸ…±οΈ Complete blood count
πŸ…²οΈ X-ray chest
πŸ…³οΈ ECG only

πŸ“šπŸ”† Radiation Therapy (Radiotherapy)

πŸ“˜ Highly Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Medical-Surgical Nursing Exams


πŸ”° I. Definition:

Radiation Therapy is the use of high-energy radiation (such as X-rays, gamma rays, or electrons) to destroy or damage cancer cells by breaking their DNA and preventing their ability to divide and grow.

β€œRadiotherapy is a localized cancer treatment that targets tumors with ionizing radiation to kill or shrink malignant cells while preserving surrounding normal tissue.”


πŸ“– II. Classification / Types:

TypeDescription
External Beam Radiation Therapy (EBRT)Most common; radiation delivered from outside the body
Internal Radiation (Brachytherapy)Radioactive sources placed inside or near the tumor
Systemic Radiation TherapyRadioactive substances (e.g., Iodine-131) taken orally or IV to target specific cancers

πŸ“– III. Causes / Indications:

  • Head and neck cancers
  • Brain tumors
  • Breast and prostate cancer
  • Cervical and uterine cancers
  • Lung cancer
  • Palliative care: Relieve pain, bleeding, or compression
  • As adjuvant therapy: After surgery or chemotherapy

πŸ“– IV. Pathophysiology (In Brief):

  1. Ionizing radiation damages cellular DNA, especially in rapidly dividing cancer cells.
  2. Leads to cell death or loss of reproductive ability.
  3. Normal tissues can also be affected but have a better capacity for repair.
  4. Fractionated doses allow maximum tumor destruction with minimal normal tissue damage.

πŸ“– V. Clinical Manifestations (Side Effects):

Localized side effects depending on area treated:

  • Skin: Redness, dryness, peeling, radiation burns
  • Head & neck: Mucositis, dry mouth, taste change
  • Chest: Cough, difficulty swallowing, pneumonitis
  • Abdomen/pelvis: Diarrhea, nausea, cystitis
  • General: Fatigue, anorexia, immunosuppression

πŸ“– VI. Diagnostic Evaluation:

  • CT/MRI/PET scans: To localize the tumor precisely
  • Simulation planning: 3D imaging to map treatment fields
  • Blood tests: CBC, renal, liver function (for baseline)
  • Consent and safety checks prior to therapy

πŸ“– VII. Management:

🟒 1. Treatment Planning:

  • Simulation: Mapping of target site
  • Dose calculation: Total radiation dose and fractionation schedule
  • Shielding: To protect nearby organs (e.g., lead shields)

🟒 2. During Treatment:

  • Delivered daily (Mon–Fri) over several weeks
  • Patients must remain still during treatment

🟒 3. Supportive Therapy:

  • Skin care: Non-irritating moisturizers, no perfumed soaps
  • Oral care for mucositis
  • Anti-emetics, analgesics as needed
  • Nutritional support

πŸ“– VIII. Nursing Responsibilities:

  • Provide pre-radiation education (expectations, precautions)
  • Assess and monitor for skin and mucosal reactions
  • Educate on skin care and hygiene
  • Monitor for fatigue, nutrition, hydration
  • Support emotional needs and body image concerns
  • Reinforce radiation safety precautions (internal therapy)
  • Encourage rest and light activity

πŸ“š Golden One-Liners for Quick Revision:

  • Radiotherapy damages DNA of cancer cells
  • EBRT is the most common form
  • Brachytherapy delivers radiation from inside the body
  • Skin care is crucial β†’ avoid perfumed products or scrubbing
  • Fatigue is the most common generalized side effect
  • Fractionated dose = safer and more effective

βœ… Top 5 MCQs for Practice:

Q1. The most common type of radiation therapy is:
πŸ…°οΈ Systemic radiation
πŸ…±οΈ Brachytherapy
βœ… πŸ…²οΈ External beam radiation therapy (EBRT)
πŸ…³οΈ Proton therapy


Q2. Radiation therapy primarily works by:
πŸ…°οΈ Increasing blood flow to tumor
βœ… πŸ…±οΈ Damaging DNA in cancer cells
πŸ…²οΈ Boosting immune response
πŸ…³οΈ Causing muscle contraction


Q3. Which is a common side effect of radiation to the abdominal area?
πŸ…°οΈ Alopecia
βœ… πŸ…±οΈ Diarrhea
πŸ…²οΈ Dry mouth
πŸ…³οΈ Bone pain


Q4. Brachytherapy involves:
πŸ…°οΈ External radiation beams
βœ… πŸ…±οΈ Internal placement of radioactive sources
πŸ…²οΈ IV chemotherapy
πŸ…³οΈ Surgical tumor removal


Q5. What should a nurse advise regarding skin care during radiation?
πŸ…°οΈ Use alcohol-based lotions
πŸ…±οΈ Apply talcum powder
βœ… πŸ…²οΈ Use mild soap and avoid scrubbing
πŸ…³οΈ Use ice packs daily

πŸ“šπŸ§¬ Immunotherapy (Biological Therapy)

πŸ“˜ Highly Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Medical-Surgical Nursing Exams


πŸ”° I. Definition:

Immunotherapy is a cancer treatment that uses the body’s immune system to fight cancer by enhancing or restoring the ability of immune cells to detect and destroy cancer cells.

β€œImmunotherapy is a biologic therapy that stimulates or manipulates the immune system to recognize and kill cancer cells more effectively.”


πŸ“– II. Classification / Types:

TypeDescription
Checkpoint InhibitorsBlock immune checkpoints (e.g., PD-1, CTLA-4) to enhance T-cell activity
Monoclonal Antibodies (mAbs)Lab-made antibodies that bind specific cancer cell markers (e.g., Rituximab)
CytokinesImmune system modulators like interleukins and interferons
Cancer VaccinesStimulate immune response against cancer (e.g., HPV vaccine)
CAR-T Cell TherapyT-cells are genetically modified to target cancer cells
Oncolytic Virus TherapyUses genetically modified viruses to kill cancer cells and stimulate immunity

πŸ“– III. Causes / Indications:

  • Melanoma
  • Non-small cell lung cancer (NSCLC)
  • Renal cell carcinoma
  • Hodgkin’s lymphoma
  • Bladder, head & neck cancers
  • Leukemias (CAR-T cell therapy)
  • Used in refractory or relapsed cancers

πŸ“– IV. Pathophysiology (In Brief):

  1. Cancer cells can evade immune detection by suppressing immune checkpoints.
  2. Immunotherapy works by releasing these brakes or activating immune cells.
  3. Immune cells (especially T-cells) recognize and destroy cancer cells.
  4. This response can be tumor-specific, long-lasting, and self-sustaining in some patients.

πŸ“– V. Clinical Manifestations (Side Effects):

Immune-Related Adverse Events (irAEs):

  • Skin: Rash, pruritus
  • GI: Colitis, diarrhea
  • Endocrine: Hypothyroidism, adrenal insufficiency
  • Lung: Pneumonitis (cough, dyspnea)
  • Liver: Hepatitis, elevated liver enzymes
  • Flu-like symptoms: Fever, chills, fatigue

πŸ“– VI. Diagnostic Evaluation:

  • Baseline labs: CBC, LFT, RFT, TSH
  • Tumor markers and imaging to assess response
  • Autoimmune panels (if suspected irAEs)
  • ECG/ECHO for cardiac status (in some mAbs)
  • Pulmonary function tests if pneumonitis suspected

πŸ“– VII. Management:

🟒 1. Immunotherapy Administration:

  • Given IV (most common) or subcutaneously
  • Administered in cycles over weeks/months
  • Requires monitoring for delayed side effects

🟒 2. Management of Side Effects:

  • Corticosteroids (e.g., prednisone) for severe irAEs
  • Thyroid hormone replacement for hypothyroidism
  • Antidiarrheals and hydration for colitis
  • Immunosuppressants if unresponsive to steroids

πŸ“– VIII. Nursing Responsibilities:

  • Monitor for immune-related adverse effects (fever, diarrhea, rash, SOB)
  • Administer medications and hydration as prescribed
  • Provide emotional support and manage treatment anxiety
  • Educate on:
    • Delayed onset of symptoms (up to weeks after treatment)
    • Reporting any new symptoms promptly
    • Importance of treatment adherence and follow-up labs
  • Encourage nutritional support and rest

πŸ“š Golden One-Liners for Quick Revision:

  • Immunotherapy enhances natural immune response against cancer
  • Checkpoint inhibitors block signals that prevent T-cell attack
  • CAR-T therapy is genetically engineered T-cell therapy
  • Main side effects are immune-related, not cytotoxic
  • Treated with steroids or immunosuppressants, not chemo drugs

βœ… Top 5 MCQs for Practice:

Q1. The main mechanism of immunotherapy is to:
πŸ…°οΈ Kill cancer cells directly
πŸ…±οΈ Suppress all immune activity
βœ… πŸ…²οΈ Stimulate the immune system to fight cancer
πŸ…³οΈ Increase chemotherapy absorption


Q2. Which of the following is a type of checkpoint inhibitor?
πŸ…°οΈ Interleukin-2
πŸ…±οΈ Cisplatin
βœ… πŸ…²οΈ Nivolumab
πŸ…³οΈ Doxorubicin


Q3. Which cancer is commonly treated with CAR-T cell therapy?
πŸ…°οΈ Breast cancer
πŸ…±οΈ Colon cancer
βœ… πŸ…²οΈ Acute lymphoblastic leukemia
πŸ…³οΈ Basal cell carcinoma


Q4. A major nursing concern with immunotherapy is:
πŸ…°οΈ Nausea and vomiting
πŸ…±οΈ Anemia
βœ… πŸ…²οΈ Autoimmune-type side effects (e.g., rash, colitis)
πŸ…³οΈ Fluid retention


Q5. Which of the following is used to manage immune-related side effects?
πŸ…°οΈ Antibiotics
βœ… πŸ…±οΈ Corticosteroids
πŸ…²οΈ Iron supplements
πŸ…³οΈ Growth factors

πŸ“šπŸ©Ί Oral Cancer

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Oral Cancer is a malignant growth occurring in any part of the oral cavity, including the lips, tongue, cheeks, floor of the mouth, hard and soft palate, sinuses, and pharynx. It is a common form of head and neck cancer and is often associated with lifestyle habits.

βœ… β€œOral cancer is a malignant neoplasm of the oral cavity characterized by uncontrolled growth of abnormal cells, which can invade surrounding tissues and metastasize.”


πŸ“– II. Common Sites of Oral Cancer

  • Lips (Lower Lip Most Common).
  • Lateral Borders of the Tongue.
  • Floor of the Mouth.
  • Buccal Mucosa (Cheeks).
  • Hard and Soft Palate.
  • Oropharynx and Tonsillar Region.

πŸ“– III. Causes / Risk Factors

  • Tobacco Use (Smoking and Chewing) – Main cause.
  • Alcohol Consumption – Synergistic effect with tobacco.
  • Betel Nut (Areca Nut) Chewing.
  • Poor Oral Hygiene and Dental Irritants.
  • HPV Infection (Human Papillomavirus).
  • Chronic Mechanical Irritation (Sharp Teeth, Ill-Fitting Dentures).
  • Prolonged Sun Exposure (Lip Cancer).
  • Nutritional Deficiencies (Iron, Vitamin A, and C).
  • Age Above 40 Years.

πŸ“– IV. Pathophysiology

  1. Exposure to carcinogens leads to genetic mutations in epithelial cells.
  2. Uncontrolled proliferation of abnormal cells leads to tumor formation.
  3. Tumor invades adjacent tissues and can spread to regional lymph nodes and distant organs (metastasis).
  4. Common histological type: Squamous Cell Carcinoma (90-95%).

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • Non-healing ulcer or sore in the mouth (>2 weeks).
  • Painless lump or thickening in the oral cavity.
  • White patches (Leukoplakia) or Red patches (Erythroplakia).
  • Difficulty in chewing, swallowing (Dysphagia), and speaking.
  • Persistent sore throat or hoarseness.
  • Unexplained bleeding in the mouth.
  • Numbness of the tongue or other parts of the mouth.
  • Swelling of jaw or loosening of teeth.
  • Weight loss and fatigue in advanced stages.

πŸ“– VI. Diagnostic Evaluation

TestPurpose
Oral ExaminationInspection for visible lesions or ulcers.
BiopsyConfirms diagnosis (Gold Standard).
CT Scan / MRI of Head and NeckAssess local invasion and lymph node involvement.
PET ScanDetect distant metastasis.
Fine Needle Aspiration Cytology (FNAC)Lymph node involvement.
HPV DNA TestingIn cases of suspected HPV-related cancers.

πŸ“– VII. Management

🟒 A. Preventive and Supportive Care:

  • Tobacco and Alcohol Cessation Programs.
  • Promote good oral hygiene and regular dental check-ups.
  • Public awareness about early signs of oral cancer.
  • HPV Vaccination to reduce virus-associated cancers.

🟑 B. Treatment Modalities:

TreatmentPurpose
SurgeryWide excision of tumor, Mandibulectomy if required.
RadiotherapyAlone or post-surgery to reduce recurrence.
ChemotherapyUsed in advanced cases or along with radiotherapy.
Targeted TherapyCetuximab for HPV-positive tumors.
Reconstructive SurgeryTo restore appearance and function post-tumor removal.

πŸ“– VIII. Nurse’s Role in Oral Cancer Management

  • Educate patients on early warning signs and prevention strategies.
  • Provide psychological support and counseling.
  • Assist in nutritional management (soft, high-protein diet post-surgery).
  • Care for surgical wounds and maintain oral hygiene.
  • Monitor for side effects of radiotherapy (mucositis, xerostomia) and chemotherapy.
  • Support patients with speech therapy and rehabilitation after surgery.


πŸ“š Golden One-Liners for Quick Revision:

  • Leukoplakia and Erythroplakia are pre-cancerous lesions of oral cancer.
  • Squamous Cell Carcinoma is the most common type of oral cancer.
  • Smoking and chewing tobacco are the leading risk factors.
  • Biopsy is the gold standard for diagnosis.
  • HPV vaccination can help prevent HPV-related oropharyngeal cancers.


βœ… Top 5 MCQs for Practice

Q1. What is the most common histological type of oral cancer?
πŸ…°οΈ Adenocarcinoma
βœ… πŸ…±οΈ Squamous Cell Carcinoma
πŸ…²οΈ Basal Cell Carcinoma
πŸ…³οΈ Sarcoma


Q2. Which of the following is considered a pre-cancerous lesion of the oral cavity?
πŸ…°οΈ Oral thrush
πŸ…±οΈ Canker sores
βœ… πŸ…²οΈ Leukoplakia
πŸ…³οΈ Dental caries


Q3. What is the gold standard test for diagnosing oral cancer?
πŸ…°οΈ CT Scan
πŸ…±οΈ MRI
πŸ…²οΈ HPV Testing
βœ… πŸ…³οΈ Biopsy


Q4. Which lifestyle factor has the strongest association with oral cancer?
πŸ…°οΈ High sugar intake
πŸ…±οΈ Coffee consumption
βœ… πŸ…²οΈ Tobacco use
πŸ…³οΈ Sedentary lifestyle


Q5. Which of the following vaccines helps prevent oropharyngeal cancer?
πŸ…°οΈ Hepatitis B vaccine
βœ… πŸ…±οΈ HPV vaccine
πŸ…²οΈ Influenza vaccine
πŸ…³οΈ Measles vaccine

πŸ“šπŸ©Ί Lung Cancer

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Lung Cancer is a malignant tumor originating in the tissues of the lungs, primarily from the lining of the bronchi or alveoli. It is one of the most common and deadliest cancers worldwide, often associated with smoking and environmental exposures.

βœ… β€œLung cancer is an uncontrolled growth of abnormal cells in one or both lungs that can invade nearby tissues and spread to distant organs (metastasis).”


πŸ“– II. Types of Lung Cancer

TypeDescriptionCommon Sites
Non-Small Cell Lung Cancer (NSCLC)85% of cases, slower growing.Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma.
Small Cell Lung Cancer (SCLC)15% of cases, aggressive and fast-growing.Strongly linked to smoking.
MesotheliomaCancer of the pleura (often linked to asbestos exposure).Pleural cavity.

πŸ“– III. Causes / Risk Factors

  • Tobacco Smoking (Most significant risk factor).
  • Second-hand Smoke Exposure.
  • Occupational Exposure: Asbestos, arsenic, radon gas, silica dust.
  • Air Pollution and Industrial Fumes.
  • Radiation Exposure (including prior cancer therapies).
  • Genetic Predisposition.
  • Chronic Lung Diseases: COPD, Pulmonary Fibrosis.

πŸ“– IV. Pathophysiology

  1. Exposure to carcinogens leads to genetic mutations in lung epithelial cells.
  2. Uncontrolled proliferation of abnormal cells forms tumors.
  3. Tumor invades bronchial walls, lung parenchyma, and spreads to lymph nodes and distant organs via the bloodstream and lymphatics (metastasis).
  4. Common sites of metastasis include brain, bones, liver, and adrenal glands.

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • Persistent, worsening cough.
  • Hemoptysis (coughing up blood).
  • Chest pain or discomfort.
  • Dyspnea (shortness of breath).
  • Hoarseness of voice (recurrent laryngeal nerve involvement).
  • Unexplained weight loss and fatigue.
  • Recurrent respiratory infections (pneumonia, bronchitis).
  • Clubbing of fingers in chronic hypoxia.
  • Superior Vena Cava Syndrome (Facial swelling and cyanosis in advanced disease).

πŸ“– VI. Diagnostic Evaluation

TestPurpose
Chest X-rayInitial imaging to detect masses or lesions.
CT Scan of ChestDetailed imaging for tumor size, location, and lymph node involvement.
Bronchoscopy with BiopsyGold standard for obtaining tissue samples.
Sputum CytologyDetect malignant cells in sputum.
PET ScanDetect metastasis.
MRI of BrainAssess for brain metastases.
Pulmonary Function Tests (PFTs)Assess lung function before surgery.

πŸ“– VII. Management

🟒 A. Preventive and Supportive Care:

  • Smoking Cessation Programs.
  • Reduce occupational exposures to carcinogens.
  • Encourage participation in lung cancer screening with Low-Dose CT Scan (LDCT) for high-risk individuals.

🟑 B. Treatment Modalities:

TreatmentPurpose
Surgery (Lobectomy, Pneumonectomy)For early-stage NSCLC.
RadiotherapyUsed alone or with chemotherapy in advanced cases.
ChemotherapyCommonly used in SCLC and advanced NSCLC.
Targeted TherapyEGFR inhibitors (e.g., Erlotinib), ALK inhibitors (e.g., Crizotinib).
ImmunotherapyCheckpoint inhibitors like Nivolumab, Pembrolizumab.
Palliative CarePain management and symptom relief in advanced cases.

πŸ“– VIII. Nurse’s Role in Lung Cancer Management

  • Encourage and support smoking cessation efforts.
  • Educate about early warning signs and importance of screening.
  • Provide care before and after thoracic surgeries.
  • Monitor for chemotherapy and radiotherapy side effects.
  • Provide psychological support and counseling to patients and families.
  • Assist in oxygen therapy and breathing exercises to improve lung function.


πŸ“š Golden One-Liners for Quick Revision:

  • Smoking is the leading cause of lung cancer.
  • Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer.
  • Low-Dose CT Scan (LDCT) is recommended for screening in high-risk individuals.
  • Bronchoscopy with biopsy is the gold standard diagnostic test.
  • Small Cell Lung Cancer (SCLC) is highly aggressive and associated with early metastasis.


βœ… Top 5 MCQs for Practice

Q1. What is the most common type of lung cancer?
πŸ…°οΈ Small Cell Lung Cancer
βœ… πŸ…±οΈ Non-Small Cell Lung Cancer
πŸ…²οΈ Mesothelioma
πŸ…³οΈ Sarcoma


Q2. Which test is considered the gold standard for diagnosing lung cancer?
πŸ…°οΈ Sputum cytology
πŸ…±οΈ Chest X-ray
βœ… πŸ…²οΈ Bronchoscopy with biopsy
πŸ…³οΈ Pulmonary function test


Q3. Which therapy targets EGFR mutations in lung cancer?
πŸ…°οΈ Chemotherapy
πŸ…±οΈ Immunotherapy
βœ… πŸ…²οΈ Targeted therapy (Erlotinib)
πŸ…³οΈ Radiotherapy


Q4. Which of the following is an early warning sign of lung cancer?
πŸ…°οΈ Sudden weight gain
πŸ…±οΈ Hemoptysis
πŸ…²οΈ Skin rash
πŸ…³οΈ Jaundice


Q5. What is the recommended screening test for high-risk individuals for lung cancer?
πŸ…°οΈ Chest X-ray
πŸ…±οΈ MRI
βœ… πŸ…²οΈ Low-Dose CT Scan (LDCT)
πŸ…³οΈ Ultrasound

πŸ“šπŸ©Ί Breast Cancer

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Breast Cancer is a malignant tumor that originates from the cells of the breast, commonly from the lining of the milk ducts or lobules. It is the most common cancer among women worldwide and a leading cause of cancer-related deaths.

βœ… β€œBreast cancer is characterized by the uncontrolled growth of abnormal breast cells that can invade nearby tissues and metastasize to distant organs.”


πŸ“– II. Types of Breast Cancer

TypeDescription
Ductal Carcinoma In Situ (DCIS)Non-invasive, confined to milk ducts.
Invasive Ductal Carcinoma (IDC)Most common type; invades breast tissues.
Invasive Lobular Carcinoma (ILC)Starts in lobules, spreads to nearby tissues.
Triple-Negative Breast Cancer (TNBC)Lacks estrogen, progesterone, and HER2 receptors; aggressive type.
Inflammatory Breast Cancer (IBC)Rare and aggressive; involves skin changes.
Paget’s Disease of the NippleAffects nipple and areola region.

πŸ“– III. Causes / Risk Factors

  • Gender (Female, though males can also be affected).
  • Age above 40 years.
  • Family history and genetic mutations (BRCA1, BRCA2 genes).
  • Early menarche and late menopause.
  • Nulliparity or first pregnancy after 30 years.
  • Prolonged use of Hormone Replacement Therapy (HRT).
  • Obesity and sedentary lifestyle.
  • Alcohol consumption and smoking.
  • Exposure to radiation.

πŸ“– IV. Pathophysiology

  1. Genetic mutations lead to abnormal growth of breast epithelial cells.
  2. These abnormal cells proliferate uncontrollably, forming a mass or tumor.
  3. Tumor invades nearby tissues and can metastasize through blood and lymph nodes.
  4. Common metastatic sites include bones, lungs, liver, and brain.

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • Painless lump in the breast or underarm (most common early sign).
  • Change in breast size or shape.
  • Skin dimpling or puckering (Peau d’orange appearance).
  • Nipple discharge (especially bloody).
  • Inverted or retracted nipple.
  • Redness or scaling of the breast skin or nipple.
  • Swelling of the breast or arm (advanced stage).

πŸ“– VI. Diagnostic Evaluation

TestPurpose
Clinical Breast Examination (CBE)Initial physical assessment.
MammographyScreening and detection of small tumors.
Ultrasound BreastDifferentiates between cystic and solid masses.
Fine Needle Aspiration Cytology (FNAC)Initial cytological diagnosis.
Core Needle BiopsyConfirms histopathology (Gold Standard).
MRI of BreastDetects extent of tumor and metastasis.
Hormone Receptor TestsEstrogen, Progesterone, and HER2 receptor status for treatment planning.

πŸ“– VII. Management

🟒 A. Preventive and Supportive Care:

  • Encourage regular Breast Self-Examination (BSE).
  • Promote annual mammography screening after 40 years of age.
  • Educate about the importance of early detection.
  • Genetic counseling for women with BRCA mutations.

🟑 B. Treatment Modalities:

TreatmentPurpose
SurgeryLumpectomy or Mastectomy.
RadiotherapyPost-surgical to reduce recurrence.
ChemotherapyFor advanced stages or aggressive cancers.
Hormonal TherapyTamoxifen, Letrozole (used if hormone receptor-positive).
Targeted TherapyTrastuzumab (Herceptin) for HER2-positive cancers.
ImmunotherapyPembrolizumab in specific cases.

πŸ“– VIII. Nurse’s Role in Breast Cancer Management

  • Educate patients about Breast Self-Examination (BSE) techniques.
  • Provide psychological support and counseling to cope with body image changes.
  • Care for post-mastectomy wounds and monitor for complications like lymphedema.
  • Administer chemotherapy safely and manage side effects.
  • Encourage nutritional support and rehabilitation therapy.
  • Support patients participating in cancer survivor groups.


πŸ“š Golden One-Liners for Quick Revision:

  • BRCA1 and BRCA2 gene mutations increase the risk of breast cancer.
  • Mammography is the gold standard for breast cancer screening.
  • Peau d’orange appearance indicates lymphatic involvement.
  • HER2-positive cancers respond to Trastuzumab (Herceptin).
  • Monthly Breast Self-Examination should be done 5-7 days after menstruation.


βœ… Top 5 MCQs for Practice

Q1. What is the most common early symptom of breast cancer?
πŸ…°οΈ Pain in the breast
βœ… πŸ…±οΈ Painless lump in the breast
πŸ…²οΈ Nipple discharge only
πŸ…³οΈ Skin ulcer


Q2. Which test is considered the gold standard for confirming breast cancer diagnosis?
πŸ…°οΈ Mammography
πŸ…±οΈ Ultrasound
βœ… πŸ…²οΈ Core Needle Biopsy
πŸ…³οΈ MRI


Q3. Which drug is used in hormone receptor-positive breast cancer?
πŸ…°οΈ Trastuzumab
βœ… πŸ…±οΈ Tamoxifen
πŸ…²οΈ Cisplatin
πŸ…³οΈ Methotrexate


Q4. Which age group is recommended to start annual mammography screening?
πŸ…°οΈ 30 years
πŸ…±οΈ 35 years
βœ… πŸ…²οΈ 40 years
πŸ…³οΈ 50 years


Q5. The β€œPeau d’orange” appearance in breast cancer indicates:
πŸ…°οΈ Infection
πŸ…±οΈ Benign tumor
βœ… πŸ…²οΈ Lymphatic obstruction
πŸ…³οΈ Normal skin changes

πŸ“šπŸ©Ί Laryngeal Cancer

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Laryngeal Cancer is a malignancy that originates in the tissues of the larynx (voice box). It typically arises from the squamous cells lining the larynx and is strongly associated with lifestyle factors like smoking and alcohol consumption.

βœ… β€œLaryngeal cancer is a malignant tumor of the larynx, often presenting with hoarseness, throat pain, and difficulty in speaking or swallowing.”


πŸ“– II. Types of Laryngeal Cancer (Based on Site)

SiteCommon Symptoms
Supraglottic (Above vocal cords)Sore throat, difficulty swallowing.
Glottic (Vocal cords)Hoarseness of voice (most common site).
Subglottic (Below vocal cords)Breathing difficulty, advanced disease symptoms.

πŸ“– III. Causes / Risk Factors

  • Tobacco Smoking (Major Risk Factor).
  • Excessive Alcohol Consumption.
  • HPV Infection (Human Papillomavirus).
  • Exposure to Industrial Chemicals and Wood Dust.
  • Chronic Laryngitis and Vocal Cord Strain.
  • Age above 55 years.
  • Male Gender (Higher Incidence).

πŸ“– IV. Pathophysiology

  1. Exposure to carcinogens leads to mutation in laryngeal epithelial cells.
  2. Uncontrolled proliferation of abnormal cells results in tumor formation.
  3. The tumor may invade the vocal cords, airway structures, and metastasize to cervical lymph nodes and distant organs.

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • Persistent hoarseness of voice (>2 weeks).
  • Sore throat and chronic cough.
  • Dysphagia (difficulty swallowing).
  • Lump or swelling in the neck (lymphadenopathy).
  • Stridor or breathing difficulty (advanced cases).
  • Ear pain (referred otalgia).
  • Unintentional weight loss and fatigue.
  • Hemoptysis (rare in advanced cases).

πŸ“– VI. Diagnostic Evaluation

TestPurpose
Laryngoscopy (Direct/Indirect)Visual examination of larynx and tumor localization.
BiopsyConfirms diagnosis (Gold Standard).
CT Scan / MRI of NeckAssess tumor extent and lymph node involvement.
PET ScanDetect distant metastasis.
Chest X-rayRule out lung metastasis.

πŸ“– VII. Management

🟒 A. Preventive and Supportive Care:

  • Smoking and Alcohol Cessation Programs.
  • Early treatment of chronic laryngitis and throat infections.
  • Use of HPV Vaccination to reduce risk.
  • Educate high-risk individuals about early warning signs.

🟑 B. Treatment Modalities:

TreatmentPurpose
RadiotherapyFirst-line treatment for early-stage tumors.
SurgeryPartial or Total Laryngectomy based on tumor extent.
ChemotherapyFor advanced disease or combined with radiation.
Targeted TherapyCetuximab for EGFR-positive tumors.
Voice RehabilitationPost-laryngectomy speech therapy.

πŸ“– VIII. Nurse’s Role in Laryngeal Cancer Management

  • Assist in pre-operative counseling and preparation for laryngectomy.
  • Provide tracheostomy care if performed post-surgery.
  • Educate patients on alternative communication methods (electrolarynx, writing, esophageal speech).
  • Monitor for complications like aspiration, infection, and airway obstruction.
  • Provide emotional and psychological support to cope with body image and speech loss.
  • Support in nutritional therapy as swallowing difficulties are common.


πŸ“š Golden One-Liners for Quick Revision:

  • Glottic cancer is the most common type of laryngeal cancer.
  • Persistent hoarseness of voice is the earliest symptom.
  • Direct laryngoscopy with biopsy is the gold standard for diagnosis.
  • Total laryngectomy leads to permanent loss of natural voice; requires speech rehabilitation.
  • HPV vaccination can reduce the risk of head and neck cancers.


βœ… Top 5 MCQs for Practice

Q1. What is the most common early symptom of laryngeal cancer?
πŸ…°οΈ Neck swelling
βœ… πŸ…±οΈ Persistent hoarseness of voice
πŸ…²οΈ Cough with hemoptysis
πŸ…³οΈ Difficulty breathing


Q2. Which diagnostic test is considered the gold standard for diagnosing laryngeal cancer?
πŸ…°οΈ Chest X-ray
πŸ…±οΈ Ultrasound of Neck
βœ… πŸ…²οΈ Direct Laryngoscopy with Biopsy
πŸ…³οΈ PET Scan


Q3. What is the main risk factor associated with laryngeal cancer?
πŸ…°οΈ Diabetes
βœ… πŸ…±οΈ Tobacco smoking
πŸ…²οΈ Hypertension
πŸ…³οΈ Low fiber diet


Q4. Which type of surgery involves complete removal of the larynx?
πŸ…°οΈ Partial Laryngectomy
βœ… πŸ…±οΈ Total Laryngectomy
πŸ…²οΈ Glossectomy
πŸ…³οΈ Thyroidectomy


Q5. What is the primary nursing responsibility after laryngectomy?
πŸ…°οΈ Encourage oral feeding immediately
πŸ…±οΈ Avoid communication with the patient
βœ… πŸ…²οΈ Provide tracheostomy care and facilitate alternative communication
πŸ…³οΈ Keep the patient in a supine position

πŸ“šπŸ©Ί Stomach Cancer (Gastric Cancer)

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Stomach Cancer, also known as Gastric Cancer, is a malignant tumor that arises from the lining of the stomach, most commonly from glandular epithelium. It is often diagnosed at an advanced stage due to vague early symptoms.

βœ… β€œGastric cancer is a malignant neoplasm of the stomach characterized by abnormal, uncontrolled cell growth, which can invade nearby tissues and metastasize to distant organs.”


πŸ“– II. Types of Stomach Cancer

TypeDescription
AdenocarcinomaMost common (95%); originates from glandular cells of the stomach lining.
LymphomaCancer of lymphatic tissue in the stomach (e.g., MALT lymphoma).
Gastrointestinal Stromal Tumor (GIST)Arises from mesenchymal tissue.
Carcinoid TumorsOriginate from neuroendocrine cells.

πŸ“– III. Causes / Risk Factors

  • Infection with Helicobacter pylori (H. pylori) – Major risk factor.
  • Diet high in smoked, salted, and pickled foods.
  • Smoking and alcohol consumption.
  • Chronic gastritis and gastric ulcers.
  • Pernicious anemia (Vitamin B12 deficiency).
  • Family history and genetic factors (CDH1 gene mutation).
  • Previous partial gastrectomy.
  • Obesity and sedentary lifestyle.

πŸ“– IV. Pathophysiology

  1. Chronic inflammation due to H. pylori or other irritants leads to gastric mucosal damage.
  2. Progression through stages: Chronic Gastritis β†’ Atrophic Gastritis β†’ Intestinal Metaplasia β†’ Dysplasia β†’ Carcinoma.
  3. Tumor invades deeper layers of the stomach wall and may spread via the lymphatic system and bloodstream.
  4. Common sites of metastasis: Liver, lungs, peritoneum, and bones.

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • Early Stage (Often Asymptomatic or Nonspecific):
    • Indigestion, bloating after meals.
    • Mild discomfort in the upper abdomen.
    • Loss of appetite.
  • Late Stage (Advanced Disease):
    • Unintentional weight loss and fatigue.
    • Persistent abdominal pain or discomfort.
    • Nausea and vomiting (sometimes with blood).
    • Melena (black, tarry stools).
    • Dysphagia (difficulty swallowing) if tumor near cardia.
    • Palpable abdominal mass in advanced cases.

πŸ“– VI. Diagnostic Evaluation

TestPurpose
Upper GI Endoscopy (EGD)Visualizes tumor; biopsy for confirmation (Gold Standard).
Barium Swallow X-rayDetects filling defects in the stomach.
CT Scan of Abdomen and PelvisEvaluates tumor spread and metastasis.
PET ScanDetects distant metastases.
Tumor MarkersCEA, CA 19-9 (used for monitoring).
H. pylori TestingUrea breath test, stool antigen test.

πŸ“– VII. Management

🟒 A. Preventive and Supportive Care:

  • Eradication of H. pylori infection.
  • Dietary modifications to reduce intake of smoked and salted foods.
  • Encourage early screening in high-risk individuals.
  • Promote healthy lifestyle and avoid tobacco and alcohol.

🟑 B. Treatment Modalities:

TreatmentPurpose
Surgical Management– Partial or Total Gastrectomy (main curative treatment).
Chemotherapy– Neoadjuvant or adjuvant to shrink tumor and prevent recurrence.
Radiotherapy– Often combined with chemotherapy.
Targeted Therapy– Trastuzumab for HER2-positive tumors.
Palliative Care– Symptom management in advanced stages.

πŸ“– VIII. Nurse’s Role in Stomach Cancer Management

  • Assist in pre- and post-operative care for gastrectomy patients.
  • Provide nutritional counseling, including advice on small, frequent meals and high-protein diets.
  • Educate patients on the signs of dumping syndrome post-gastrectomy.
  • Monitor for complications such as anemia, vitamin B12 deficiency, and weight loss.
  • Provide psychological support and counseling.
  • Educate about H. pylori eradication therapy and its importance.


πŸ“š Golden One-Liners for Quick Revision:

  • Adenocarcinoma is the most common type of gastric cancer.
  • H. pylori infection is the primary risk factor.
  • Endoscopy with biopsy is the gold standard for diagnosis.
  • Dumping syndrome is a common complication after gastrectomy.
  • Trastuzumab is used in HER2-positive gastric cancers.


βœ… Top 5 MCQs for Practice

Q1. Which infection is most commonly associated with gastric cancer?
πŸ…°οΈ E. coli
βœ… πŸ…±οΈ H. pylori
πŸ…²οΈ Streptococcus
πŸ…³οΈ Salmonella


Q2. What is the gold standard diagnostic test for stomach cancer?
πŸ…°οΈ Barium swallow X-ray
βœ… πŸ…±οΈ Endoscopy with biopsy
πŸ…²οΈ PET scan
πŸ…³οΈ Abdominal ultrasound


Q3. Which type of gastric cancer is most common?
πŸ…°οΈ Lymphoma
βœ… πŸ…±οΈ Adenocarcinoma
πŸ…²οΈ Carcinoid tumor
πŸ…³οΈ Sarcoma


Q4. What is a common post-gastrectomy complication?
πŸ…°οΈ Hypertension
πŸ…±οΈ Constipation
βœ… πŸ…²οΈ Dumping syndrome
πŸ…³οΈ Hyperglycemia


Q5. Which tumor marker is associated with monitoring gastric cancer?
πŸ…°οΈ PSA
πŸ…±οΈ CA-125
βœ… πŸ…²οΈ CA 19-9
πŸ…³οΈ AFP

πŸ“šπŸ©Ί Liver Cancer (Hepatic Cancer)

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Liver Cancer is a malignant tumor that originates either in the liver cells (primary liver cancer) or spreads to the liver from other organs (secondary/metastatic cancer). The most common primary liver cancer is Hepatocellular Carcinoma (HCC).

βœ… β€œLiver cancer is a malignancy of liver cells, primarily caused by chronic liver disease and viral hepatitis infections, leading to abnormal and uncontrolled cell proliferation.”


πŸ“– II. Types of Liver Cancer

TypeDescription
Hepatocellular Carcinoma (HCC)Most common primary liver cancer, originates from hepatocytes.
CholangiocarcinomaCancer of the bile ducts (also called bile duct cancer).
HepatoblastomaRare, primarily seen in children.
Secondary (Metastatic) Liver CancerCancer that spreads to the liver from other organs (e.g., colon, breast, lungs).

πŸ“– III. Causes / Risk Factors

  • Chronic Hepatitis B and C Virus Infections (HBV, HCV).
  • Cirrhosis of Liver (Alcoholic or Non-Alcoholic).
  • Non-Alcoholic Fatty Liver Disease (NAFLD).
  • Excessive Alcohol Consumption.
  • Exposure to Aflatoxins (Moldy Grains and Nuts).
  • Genetic Disorders: Hemochromatosis, Wilson’s Disease.
  • Obesity and Diabetes Mellitus.
  • Family History of Liver Cancer.

πŸ“– IV. Pathophysiology

  1. Chronic liver injury due to viral infection, alcohol, or toxins leads to inflammation and liver cell damage.
  2. Regenerative nodules and genetic mutations in hepatocytes promote malignant transformation.
  3. Tumor invades blood vessels and spreads via the portal vein and hepatic veins.
  4. Common metastasis sites: Lungs, bones, and peritoneum.

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • Early Stage (Often Asymptomatic):
    • Right upper quadrant discomfort or mild pain.
    • Fatigue and general weakness.
  • Late Stage (Advanced Disease):
    • Significant weight loss and anorexia.
    • Abdominal swelling due to ascites.
    • Jaundice (yellowing of skin and eyes).
    • Palpable liver mass or hepatomegaly.
    • Portal hypertension and variceal bleeding.
    • Edema in lower limbs.
    • Encephalopathy (confusion, altered mental status).

πŸ“– VI. Diagnostic Evaluation

TestPurpose
Serum Alpha-Fetoprotein (AFP)Tumor marker; elevated in HCC.
Liver Function Tests (LFTs)Assess liver damage and function.
Ultrasound AbdomenInitial screening test for liver masses.
CT Scan / MRI of LiverDetailed imaging for tumor size and spread.
PET ScanDetect distant metastasis.
Liver BiopsyConfirms histological diagnosis (Gold Standard).
HBV and HCV SerologyDetermine viral infection status.

πŸ“– VII. Management

🟒 A. Preventive and Supportive Care:

  • Hepatitis B Vaccination to prevent HBV infection.
  • Early treatment of Hepatitis B and C infections.
  • Avoid excessive alcohol consumption and manage NAFLD.
  • Regular screening for high-risk patients (e.g., cirrhosis patients).

🟑 B. Treatment Modalities:

TreatmentPurpose
Surgical ResectionCurative in localized tumors without cirrhosis.
Liver TransplantationBest option for eligible patients with end-stage liver disease and small tumors.
Radiofrequency Ablation (RFA)Used for small tumors to destroy cancer cells.
Transarterial Chemoembolization (TACE)Used to block tumor blood supply and deliver chemotherapy.
Targeted TherapySorafenib, Lenvatinib for advanced HCC.
ImmunotherapyNivolumab, Pembrolizumab in advanced cases.
Palliative CareSymptom management in terminal stages.

πŸ“– VIII. Nurse’s Role in Liver Cancer Management

  • Educate patients about HBV vaccination and prevention strategies.
  • Assist in managing symptoms like ascites, jaundice, and encephalopathy.
  • Monitor and support patients undergoing chemotherapy, TACE, and immunotherapy.
  • Provide nutritional support to prevent malnutrition.
  • Offer psychological support and counseling for patients and families.
  • Ensure proper care for patients on palliative and hospice care.


πŸ“š Golden One-Liners for Quick Revision:

  • Hepatocellular carcinoma (HCC) is the most common type of liver cancer.
  • Chronic HBV and HCV infections are the leading causes of liver cancer.
  • Alpha-Fetoprotein (AFP) is a key tumor marker for HCC.
  • TACE and RFA are non-surgical interventions for liver cancer management.
  • Liver transplantation offers the best curative option for eligible patients.


βœ… Top 5 MCQs for Practice

Q1. What is the most common primary liver cancer?
πŸ…°οΈ Cholangiocarcinoma
πŸ…±οΈ Hepatoblastoma
βœ… πŸ…²οΈ Hepatocellular Carcinoma
πŸ…³οΈ Adenocarcinoma


Q2. Which viral infection is a major risk factor for liver cancer?
πŸ…°οΈ HIV
πŸ…±οΈ HPV
βœ… πŸ…²οΈ Hepatitis B Virus
πŸ…³οΈ Epstein-Barr Virus


Q3. Which tumor marker is most commonly used for liver cancer detection?
πŸ…°οΈ CEA
βœ… πŸ…±οΈ AFP (Alpha-Fetoprotein)
πŸ…²οΈ CA-125
πŸ…³οΈ PSA


Q4. Which treatment modality is used to block blood supply to liver tumors?
πŸ…°οΈ RFA
πŸ…±οΈ Liver Transplant
βœ… πŸ…²οΈ TACE (Transarterial Chemoembolization)
πŸ…³οΈ Chemotherapy


Q5. What is a common complication of advanced liver cancer?
πŸ…°οΈ Hypertension
πŸ…±οΈ Diabetes
βœ… πŸ…²οΈ Ascites
πŸ…³οΈ Hypothyroidism

πŸ“šπŸ©Ί Colon Cancer (Colorectal Cancer)

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Colon Cancer, also known as Colorectal Cancer when involving the rectum, is a malignancy that develops from the inner lining of the large intestine (colon) and/or rectum. It often begins as a benign polyp, which may become cancerous over time.

βœ… β€œColon cancer is a malignant tumor of the large intestine characterized by abnormal cell growth, which can invade surrounding tissues and metastasize.”


πŸ“– II. Types of Colon Cancer

TypeDescription
AdenocarcinomaMost common (95%), arises from glandular epithelial cells.
Carcinoid TumorOriginates from neuroendocrine cells.
Gastrointestinal Stromal Tumor (GIST)Arises from connective tissue of the intestine.
LymphomaRare, involves lymphoid tissue in the colon.

πŸ“– III. Causes / Risk Factors

  • Age above 50 years.
  • Family history of colorectal cancer or polyps.
  • Genetic Syndromes: Familial Adenomatous Polyposis (FAP), Lynch Syndrome.
  • Diet high in red and processed meats, low in fiber.
  • Sedentary lifestyle and obesity.
  • Smoking and excessive alcohol consumption.
  • Inflammatory Bowel Diseases (Ulcerative Colitis, Crohn’s Disease).
  • Type 2 Diabetes Mellitus.

πŸ“– IV. Pathophysiology

  1. Mutation in tumor suppressor genes (e.g., APC gene) leads to polyp formation.
  2. Over time, benign polyps undergo dysplasia and malignant transformation.
  3. Tumor invades the muscular layers of the colon and can metastasize through blood and lymphatic vessels.
  4. Common sites of metastasis include liver, lungs, bones, and peritoneum.

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • Change in bowel habits (diarrhea or constipation).
  • Narrowing of stools (pencil-thin stools).
  • Rectal bleeding or blood in stools (hematochezia or melena).
  • Persistent abdominal pain, cramps, or bloating.
  • Unintentional weight loss and fatigue.
  • Iron deficiency anemia (due to chronic blood loss).
  • Sensation of incomplete evacuation after defecation.

πŸ“– VI. Diagnostic Evaluation

TestPurpose
Fecal Occult Blood Test (FOBT)Detects hidden blood in stool (screening test).
ColonoscopyGold standard for visualization and biopsy of suspicious lesions.
SigmoidoscopyExamines lower part of the colon.
CT Colonography (Virtual Colonoscopy)Non-invasive imaging technique.
CEA (Carcinoembryonic Antigen)Tumor marker used for monitoring.
CT Scan of Abdomen and PelvisDetects metastasis and tumor staging.
BiopsyConfirms histological diagnosis.

πŸ“– VII. Management

🟒 A. Preventive and Supportive Care:

  • Encourage regular colorectal cancer screening starting at age 45-50 years.
  • Promote a high-fiber, low-fat diet rich in fruits and vegetables.
  • Encourage regular physical activity and maintain healthy body weight.
  • Educate about the risks of tobacco and alcohol consumption.
  • Genetic counseling for individuals with a family history of colorectal cancer.

🟑 B. Treatment Modalities:

TreatmentPurpose
Surgical ResectionColectomy or Hemicolectomy to remove tumor.
ChemotherapyUsed in advanced stages or post-surgery (e.g., 5-FU, Capecitabine).
RadiotherapyMore common for rectal cancers.
Targeted TherapyCetuximab, Bevacizumab for metastatic disease.
Palliative CareSymptom relief in advanced stages.

πŸ“– VIII. Nurse’s Role in Colon Cancer Management

  • Educate patients about the importance of screening and early detection.
  • Provide pre- and post-operative care following bowel surgeries.
  • Monitor for signs of bowel obstruction or bleeding.
  • Manage chemotherapy side effects such as diarrhea, mucositis, and neutropenia.
  • Offer nutritional counseling and colostomy care if required.
  • Provide psychological support and counseling for patients and families.


πŸ“š Golden One-Liners for Quick Revision:

  • Adenocarcinoma is the most common type of colon cancer.
  • Colonoscopy is the gold standard diagnostic and screening test.
  • CEA (Carcinoembryonic Antigen) is a tumor marker used for monitoring.
  • High fiber diet and regular screening reduce the risk of colon cancer.
  • Common metastasis site for colon cancer is the liver.


βœ… Top 5 MCQs for Practice

Q1. What is the gold standard test for diagnosing colon cancer?
πŸ…°οΈ Sigmoidoscopy
πŸ…±οΈ FOBT
βœ… πŸ…²οΈ Colonoscopy
πŸ…³οΈ CT Scan


Q2. Which tumor marker is commonly used to monitor colon cancer?
πŸ…°οΈ AFP
πŸ…±οΈ CA-125
βœ… πŸ…²οΈ CEA
πŸ…³οΈ CA 19-9


Q3. What is a typical early symptom of colon cancer?
πŸ…°οΈ Vomiting
πŸ…±οΈ Increased urination
βœ… πŸ…²οΈ Change in bowel habits
πŸ…³οΈ Severe back pain


Q4. Which of the following is a known genetic risk factor for colon cancer?
πŸ…°οΈ Turner’s Syndrome
βœ… πŸ…±οΈ Lynch Syndrome
πŸ…²οΈ Down Syndrome
πŸ…³οΈ Klinefelter Syndrome


Q5. Which dietary habit increases the risk of colon cancer?
πŸ…°οΈ High fiber diet
πŸ…±οΈ Low fat diet
βœ… πŸ…²οΈ High intake of red and processed meat
πŸ…³οΈ High intake of fruits and vegetables

πŸ“šπŸ©Ί Cervical Cancer

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Cervical Cancer is a malignant tumor arising from the cervix uteri, which is the lower part of the uterus connecting to the vagina. It is the second most common cancer in women globally, highly preventable through early screening and vaccination.

βœ… β€œCervical cancer is characterized by the uncontrolled growth of abnormal cells in the cervix, commonly associated with persistent Human Papillomavirus (HPV) infection.”


πŸ“– II. Types of Cervical Cancer

TypeDescription
Squamous Cell CarcinomaMost common (80-90%), arises from the squamous epithelial lining of the cervix.
AdenocarcinomaArises from the glandular epithelial cells of the endocervix.
Adenosquamous CarcinomaContains both squamous and glandular components.

πŸ“– III. Causes / Risk Factors

  • Persistent HPV Infection (Types 16 & 18 most oncogenic).
  • Early onset of sexual activity and multiple sexual partners.
  • Smoking and tobacco use.
  • Long-term use of oral contraceptives.
  • Multiple pregnancies.
  • Poor genital hygiene.
  • HIV infection and other immunosuppressive conditions.
  • Low socioeconomic status and lack of regular screening.

πŸ“– IV. Pathophysiology

  1. HPV infection causes genetic mutations in cervical epithelial cells.
  2. Leads to precancerous changes known as Cervical Intraepithelial Neoplasia (CIN):
    • CIN I: Mild dysplasia
    • CIN II: Moderate dysplasia
    • CIN III: Severe dysplasia (Carcinoma in situ)
  3. If untreated, progresses to invasive cervical cancer, spreading to adjacent tissues (uterus, vagina, bladder) and distant metastasis via lymphatic and blood circulation.

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • Early Stage (Often Asymptomatic):
    • Post-coital bleeding (bleeding after sexual intercourse).
    • Intermenstrual bleeding.
    • Foul-smelling vaginal discharge.
  • Late Stage (Advanced Disease):
    • Persistent pelvic and lower back pain.
    • Heavy vaginal bleeding.
    • Dysuria and hematuria (bladder invasion).
    • Rectal bleeding or constipation (rectal invasion).
    • Leg swelling due to lymphatic obstruction.
    • Cachexia (severe weight loss and fatigue).

πŸ“– VI. Diagnostic Evaluation

TestPurpose
Pap Smear TestPrimary screening tool to detect precancerous changes.
HPV DNA TestingIdentifies high-risk HPV types.
ColposcopyDetailed examination of cervix using magnification.
Biopsy (Punch or Cone)Confirms histopathological diagnosis (Gold Standard).
CT/MRI PelvisFor staging and assessment of tumor spread.
Chest X-ray/ PET ScanTo detect distant metastases.

πŸ“– VII. Management

🟒 A. Preventive and Supportive Care:

  • HPV Vaccination (Cervarix, Gardasil) recommended for girls and young women aged 9-26 years.
  • Promote regular Pap Smear Screening (every 3 years from age 21-65).
  • Practice safe sexual behaviors and maintain genital hygiene.
  • Educate about early recognition of warning signs.

🟑 B. Treatment Modalities:

TreatmentPurpose
Surgical Management– Early-stage: Cone biopsy, Simple or Radical Hysterectomy.
Radiotherapy– External beam radiation and brachytherapy.
Chemotherapy– Cisplatin-based regimens often combined with radiation.
Targeted Therapy– Bevacizumab (anti-angiogenic agent) for advanced cases.
Palliative Care– Symptom management in terminal stages.

πŸ“– VIII. Nurse’s Role in Cervical Cancer Management

  • Educate on the importance of HPV vaccination and regular screening.
  • Provide pre- and post-operative care for hysterectomy patients.
  • Support patients during radiotherapy and chemotherapy.
  • Offer guidance for managing side effects like vaginal dryness, fatigue, and diarrhea.
  • Provide psychological support and emotional counseling.
  • Assist patients in palliative care and end-of-life management.


πŸ“š Golden One-Liners for Quick Revision:

  • HPV types 16 and 18 are responsible for nearly 70% of cervical cancer cases.
  • Pap smear is the most effective screening method for early detection.
  • Bevacizumab is a targeted therapy drug used in advanced cervical cancer.
  • Post-coital bleeding is a classic early warning sign of cervical cancer.
  • HPV vaccination is most effective before the onset of sexual activity.


βœ… Top 5 MCQs for Practice

Q1. What is the most common causative agent of cervical cancer?
πŸ…°οΈ Epstein-Barr Virus
βœ… πŸ…±οΈ Human Papillomavirus (HPV)
πŸ…²οΈ Herpes Simplex Virus
πŸ…³οΈ Hepatitis B Virus


Q2. Which test is considered the gold standard for diagnosing cervical cancer?
πŸ…°οΈ Pap Smear
πŸ…±οΈ HPV DNA Test
βœ… πŸ…²οΈ Cervical Biopsy
πŸ…³οΈ Colposcopy


Q3. Which age group is most appropriate for HPV vaccination?
πŸ…°οΈ 30-40 years
βœ… πŸ…±οΈ 9-26 years
πŸ…²οΈ 50-60 years
πŸ…³οΈ 65-75 years


Q4. Which symptom is an early warning sign of cervical cancer?
πŸ…°οΈ Severe abdominal pain
πŸ…±οΈ Menstrual irregularities only
βœ… πŸ…²οΈ Post-coital bleeding
πŸ…³οΈ Headache


Q5. Which chemotherapy drug is commonly used in cervical cancer treatment?
πŸ…°οΈ Methotrexate
βœ… πŸ…±οΈ Cisplatin
πŸ…²οΈ Doxorubicin
πŸ…³οΈ Tamoxifen

πŸ“šπŸ©Ί Ovarian Cancer

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Ovarian Cancer is a malignant tumor that originates in the tissues of one or both ovaries. It is often called the β€œsilent killer” because it is usually detected at an advanced stage due to vague and non-specific early symptoms.

βœ… β€œOvarian cancer is characterized by the abnormal and uncontrolled proliferation of cells in the ovaries, with a high tendency for peritoneal spread and distant metastasis.”


πŸ“– II. Types of Ovarian Cancer

TypeDescription
Epithelial TumorsMost common (85-90%); arise from the surface epithelium of the ovary.
Germ Cell TumorsCommon in younger women; arise from egg-producing cells.
Stromal TumorsArise from hormone-producing tissues.
Metastatic Ovarian CancerSecondary cancer from other primary sites like breast, colon, or stomach.

πŸ“– III. Causes / Risk Factors

  • Family History (BRCA1 and BRCA2 Mutations).
  • Age above 50 years.
  • Nulliparity or infertility.
  • Early menarche and late menopause.
  • Hormone Replacement Therapy (HRT).
  • Obesity and high-fat diet.
  • Use of fertility drugs.
  • Endometriosis.

πŸ“– IV. Pathophysiology

  1. Genetic mutations and hormonal factors lead to uncontrolled cell proliferation in the ovarian tissue.
  2. Tumor cells spread easily through the peritoneal cavity, causing ascites and implantation on peritoneal surfaces.
  3. Common metastasis sites include the liver, lungs, peritoneum, and lymph nodes.

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • Early Stage (Often Asymptomatic):
    • Mild abdominal discomfort or bloating.
    • Early satiety (feeling full quickly).
  • Late Stage (Advanced Disease):
    • Persistent abdominal bloating and distention (ascites).
    • Pelvic or abdominal pain.
    • Changes in bowel habits (constipation).
    • Unexplained weight loss.
    • Urinary frequency and urgency.
    • Menstrual irregularities.
    • Palpable pelvic or abdominal mass.

πŸ“– VI. Diagnostic Evaluation

TestPurpose
Pelvic ExaminationInitial assessment of pelvic masses.
Transvaginal Ultrasound (TVUS)Visualizes ovarian tumors.
Serum CA-125 LevelTumor marker elevated in epithelial ovarian cancer.
CT/MRI of Abdomen and PelvisAssess tumor spread and staging.
PET ScanDetect distant metastases.
Laparoscopy / Exploratory LaparotomyDirect visualization and biopsy (Gold Standard).

πŸ“– VII. Management

🟒 A. Preventive and Supportive Care:

  • Prophylactic oophorectomy in high-risk women (BRCA mutations).
  • Encourage regular pelvic exams and ultrasound screening in high-risk individuals.
  • Educate about recognizing early warning signs.
  • Genetic counseling for families with a history of ovarian or breast cancer.

🟑 B. Treatment Modalities:

TreatmentPurpose
Surgical ManagementTotal Abdominal Hysterectomy with Bilateral Salpingo-Oophorectomy (TAH-BSO) and debulking surgery.
ChemotherapyPlatinum-based agents (Cisplatin, Carboplatin) with Paclitaxel.
RadiotherapyLess commonly used but may be given for palliative care.
Targeted TherapyBevacizumab (anti-angiogenic), PARP inhibitors (Olaparib) for BRCA-positive cases.
Palliative CareSymptom management in terminal stages.

πŸ“– VIII. Nurse’s Role in Ovarian Cancer Management

  • Educate women about family history and genetic risks (BRCA testing).
  • Provide pre- and post-operative care, including abdominal wound care.
  • Manage chemotherapy side effects like nausea, vomiting, and myelosuppression.
  • Assist in the management of ascites and nutritional counseling.
  • Offer psychological support and counseling for body image changes and fertility concerns.
  • Provide care for patients in palliative and hospice care settings.


πŸ“š Golden One-Liners for Quick Revision:

  • CA-125 is the most commonly used tumor marker for ovarian cancer.
  • BRCA1 and BRCA2 mutations significantly increase ovarian cancer risk.
  • Ovarian cancer is often called the β€œsilent killer” due to late diagnosis.
  • TAH-BSO is the standard surgical procedure for advanced ovarian cancer.
  • Bevacizumab and PARP inhibitors are targeted therapies used in advanced cases.


βœ… Top 5 MCQs for Practice

Q1. Which tumor marker is most commonly used for monitoring ovarian cancer?
πŸ…°οΈ CEA
πŸ…±οΈ AFP
βœ… πŸ…²οΈ CA-125
πŸ…³οΈ CA 19-9


Q2. What is the standard surgical treatment for advanced ovarian cancer?
πŸ…°οΈ Myomectomy
πŸ…±οΈ Simple Hysterectomy
βœ… πŸ…²οΈ Total Abdominal Hysterectomy with Bilateral Salpingo-Oophorectomy (TAH-BSO)
πŸ…³οΈ Ovarian cystectomy


Q3. Which genetic mutation increases the risk of ovarian cancer?
πŸ…°οΈ BRCA1 and BRCA2
πŸ…±οΈ APC Gene
πŸ…²οΈ P53 Gene
πŸ…³οΈ RET Gene


Q4. Which chemotherapy agents are commonly used in ovarian cancer treatment?
πŸ…°οΈ Methotrexate and Doxorubicin
βœ… πŸ…±οΈ Cisplatin and Paclitaxel
πŸ…²οΈ Vincristine and Bleomycin
πŸ…³οΈ Cyclophosphamide and Tamoxifen


Q5. Which of the following is a late symptom of ovarian cancer?
πŸ…°οΈ Headache
πŸ…±οΈ Chest pain
βœ… πŸ…²οΈ Ascites and abdominal distension
πŸ…³οΈ Skin rash

πŸ“šπŸ©Ί Uterine Cancer (Endometrial Cancer)

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Uterine Cancer, commonly referred to as Endometrial Cancer, arises from the inner lining of the uterus (endometrium). It is the most common gynecological cancer and is often detected early due to abnormal uterine bleeding.

βœ… β€œUterine cancer is a malignant neoplasm of the endometrial lining characterized by abnormal cell proliferation, often presenting with postmenopausal bleeding.”


πŸ“– II. Types of Uterine Cancer

TypeDescription
Endometrial CarcinomaMost common (80-90%), arises from the endometrial lining.
Uterine SarcomaRare, arises from muscle or connective tissue of the uterus.
CarcinosarcomaMixed tumor containing both carcinoma and sarcoma components.

πŸ“– III. Causes / Risk Factors

  • Unopposed Estrogen Exposure.
  • Obesity and Metabolic Syndrome.
  • Nulliparity or Infertility.
  • Early menarche and late menopause.
  • Prolonged use of Estrogen Replacement Therapy.
  • Polycystic Ovarian Syndrome (PCOS).
  • Tamoxifen Therapy for Breast Cancer.
  • Diabetes Mellitus and Hypertension.
  • Family history of endometrial or colon cancer (Lynch Syndrome).

πŸ“– IV. Pathophysiology

  1. Prolonged estrogen exposure without progesterone balance leads to endometrial hyperplasia.
  2. Hyperplasia progresses to atypical hyperplasia and eventually to carcinoma.
  3. Cancer invades the myometrium and may spread via lymphatic channels and bloodstream.
  4. Common metastasis sites: Lungs, liver, bones, and lymph nodes.

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • Postmenopausal bleeding (classic early symptom).
  • Intermenstrual bleeding in premenopausal women.
  • Pelvic pain or cramping.
  • Abnormal watery or blood-tinged vaginal discharge.
  • Enlarged uterus or pelvic mass in advanced cases.
  • Weight loss and fatigue (in advanced stages).

πŸ“– VI. Diagnostic Evaluation

TestPurpose
Transvaginal Ultrasound (TVUS)Measures endometrial thickness (>4 mm in postmenopausal women is suspicious).
Endometrial BiopsyGold standard for diagnosis.
Hysteroscopy with BiopsyDirect visualization and sampling of endometrial tissue.
CT/MRI PelvisStaging and assessment of metastasis.
CA-125Tumor marker used for monitoring advanced disease.

πŸ“– VII. Management

🟒 A. Preventive and Supportive Care:

  • Encourage weight management and regular physical activity.
  • Manage underlying conditions like diabetes and hypertension.
  • Educate on the risks of unopposed estrogen therapy.
  • Genetic counseling for families with Lynch Syndrome.

🟑 B. Treatment Modalities:

TreatmentPurpose
Surgical ManagementTotal Abdominal Hysterectomy with Bilateral Salpingo-Oophorectomy (TAH-BSO) is the standard treatment.
RadiotherapyUsed in high-risk or advanced cases (external beam or brachytherapy).
ChemotherapyPaclitaxel and Carboplatin are commonly used.
Hormonal TherapyProgestins (e.g., Megestrol acetate) for hormone receptor-positive tumors or inoperable cases.
Palliative CareFor symptom relief in advanced stages.

πŸ“– VIII. Nurse’s Role in Uterine Cancer Management

  • Educate women about early signs such as postmenopausal bleeding.
  • Provide pre- and post-operative care after hysterectomy.
  • Support patients during radiotherapy and chemotherapy sessions.
  • Monitor for complications like lymphedema, urinary incontinence, and infection.
  • Offer emotional support and counseling, especially regarding fertility loss.
  • Provide care for patients in palliative and hospice care.


πŸ“š Golden One-Liners for Quick Revision:

  • Endometrial carcinoma is the most common type of uterine cancer.
  • Postmenopausal bleeding is the hallmark symptom.
  • Transvaginal ultrasound and endometrial biopsy are key diagnostic tools.
  • TAH-BSO is the gold standard surgical treatment.
  • Obesity and unopposed estrogen exposure are major risk factors.


βœ… Top 5 MCQs for Practice

Q1. What is the most common early symptom of uterine (endometrial) cancer?
πŸ…°οΈ Pelvic pain
βœ… πŸ…±οΈ Postmenopausal bleeding
πŸ…²οΈ Abdominal distension
πŸ…³οΈ Painful intercourse


Q2. Which diagnostic test is the gold standard for confirming endometrial cancer?
πŸ…°οΈ Pap Smear
πŸ…±οΈ CA-125 Test
βœ… πŸ…²οΈ Endometrial Biopsy
πŸ…³οΈ CT Scan


Q3. Which of the following is the standard surgical treatment for uterine cancer?
πŸ…°οΈ Myomectomy
πŸ…±οΈ Ovarian cystectomy
βœ… πŸ…²οΈ TAH-BSO (Total Abdominal Hysterectomy with Bilateral Salpingo-Oophorectomy)
πŸ…³οΈ Cervical conization


Q4. Which risk factor is most associated with endometrial hyperplasia and cancer?
πŸ…°οΈ Low estrogen levels
βœ… πŸ…±οΈ Unopposed estrogen therapy
πŸ…²οΈ High calcium intake
πŸ…³οΈ Low body weight


Q5. Which hormone therapy is used in the management of inoperable or hormone-positive endometrial cancer?
πŸ…°οΈ Tamoxifen
πŸ…±οΈ Estrogen replacement therapy
βœ… πŸ…²οΈ Progestins (Megestrol acetate)
πŸ…³οΈ Androgens

πŸ“šπŸ©Ί Prostate Cancer

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Prostate Cancer is a malignant tumor originating in the prostate gland, which is part of the male reproductive system. It typically develops slowly and is often asymptomatic in the early stages but can become aggressive and metastasize if untreated.

βœ… β€œProstate cancer is characterized by uncontrolled growth of abnormal cells in the prostate gland, commonly affecting elderly men and associated with elevated PSA levels.”


πŸ“– II. Types of Prostate Cancer

TypeDescription
AdenocarcinomaMost common type (95%), arises from glandular tissue.
Small Cell CarcinomaRare, aggressive neuroendocrine tumor.
Squamous Cell CarcinomaVery rare, poor prognosis.

πŸ“– III. Causes / Risk Factors

  • Age above 50 years (risk increases with age).
  • Family history of prostate or breast cancer.
  • African American ethnicity (higher risk and aggressive tumors).
  • High-fat diet and obesity.
  • Elevated testosterone levels.
  • Smoking and sedentary lifestyle.
  • Exposure to toxic chemicals (e.g., cadmium).

πŸ“– IV. Pathophysiology

  1. Genetic mutations and hormonal factors lead to abnormal proliferation of prostate glandular cells.
  2. Tumor invades surrounding tissues including the seminal vesicles, bladder, and rectum.
  3. Metastasis occurs via lymphatics and blood vessels, commonly affecting bones (pelvis, spine), lungs, and liver.

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • Early Stage (Often Asymptomatic):
    • Increased frequency of urination, especially at night (nocturia).
    • Weak or interrupted urine flow.
    • Difficulty starting or stopping urination.
  • Late Stage (Advanced Disease):
    • Hematuria (blood in urine).
    • Painful ejaculation.
    • Bone pain (pelvis, spine) due to metastasis.
    • Urinary retention or incontinence.
    • Weight loss and fatigue.

πŸ“– VI. Diagnostic Evaluation

TestPurpose
Digital Rectal Examination (DRE)Detects prostate enlargement or nodules.
Serum PSA (Prostate-Specific Antigen)Elevated in prostate cancer; used for screening and monitoring.
Transrectal Ultrasound (TRUS)Visualizes prostate abnormalities.
Prostate Biopsy (TRUS-guided)Gold standard for confirming diagnosis.
Bone Scan / CT / MRIDetect metastasis.
Gleason ScoreAssesses tumor aggressiveness based on biopsy.

πŸ“– VII. Management

🟒 A. Preventive and Supportive Care:

  • Encourage regular PSA screening and DRE after age 50 (earlier if high risk).
  • Promote a healthy, low-fat diet rich in fruits and vegetables.
  • Educate about the importance of physical activity and maintaining ideal body weight.

🟑 B. Treatment Modalities:

TreatmentPurpose
Active SurveillanceFor low-risk, slow-growing cancers.
Surgical ManagementRadical Prostatectomy (complete removal of the prostate).
RadiotherapyExternal Beam Radiation Therapy or Brachytherapy.
Hormone (Androgen Deprivation) TherapyReduces testosterone levels (e.g., Leuprolide, Goserelin).
ChemotherapyFor advanced or metastatic cancer (e.g., Docetaxel).
Targeted TherapyEnzalutamide, Abiraterone for advanced cases.
Palliative CareSymptom management in terminal stages.

πŸ“– VIII. Nurse’s Role in Prostate Cancer Management

  • Educate patients on PSA testing and DRE importance for early detection.
  • Provide pre- and post-operative care following prostatectomy.
  • Manage complications like urinary incontinence, sexual dysfunction, and bowel changes.
  • Monitor for side effects of hormone therapy (hot flashes, bone thinning).
  • Provide psychological support for sexual health concerns and body image issues.
  • Offer care for patients in palliative and hospice care settings.


πŸ“š Golden One-Liners for Quick Revision:

  • Adenocarcinoma is the most common type of prostate cancer.
  • PSA testing and Digital Rectal Exam (DRE) are primary screening tools.
  • Bone pain is a common sign of metastatic prostate cancer.
  • Gleason score helps determine tumor aggressiveness.
  • Hormone therapy is the mainstay for advanced prostate cancer.


βœ… Top 5 MCQs for Practice

Q1. What is the most common type of prostate cancer?
πŸ…°οΈ Squamous Cell Carcinoma
βœ… πŸ…±οΈ Adenocarcinoma
πŸ…²οΈ Small Cell Carcinoma
πŸ…³οΈ Transitional Cell Carcinoma


Q2. Which test is used to assess prostate-specific antigen levels?
πŸ…°οΈ CEA Test
βœ… πŸ…±οΈ PSA Test
πŸ…²οΈ AFP Test
πŸ…³οΈ CA-125 Test


Q3. Which hormone therapy is commonly used in advanced prostate cancer?
πŸ…°οΈ Estrogen
πŸ…±οΈ Testosterone
βœ… πŸ…²οΈ Leuprolide
πŸ…³οΈ Progesterone


Q4. Which bone is most commonly affected by metastatic prostate cancer?
πŸ…°οΈ Skull
πŸ…±οΈ Humerus
βœ… πŸ…²οΈ Pelvic Bones and Spine
πŸ…³οΈ Radius


Q5. What does a high Gleason score indicate?
πŸ…°οΈ Low-grade tumor
πŸ…±οΈ Non-cancerous tissue
βœ… πŸ…²οΈ High-grade, aggressive tumor
πŸ…³οΈ Benign prostatic hyperplasia

πŸ“šπŸ©Ί Bladder Cancer

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Bladder Cancer is a malignant tumor arising from the tissues of the urinary bladder, primarily affecting the transitional epithelium (urothelium) lining the bladder. It is more common in men and typically presents with painless hematuria.

βœ… β€œBladder cancer is characterized by uncontrolled proliferation of abnormal urothelial cells, which may invade the bladder wall and metastasize if left untreated.”


πŸ“– II. Types of Bladder Cancer

TypeDescription
Transitional Cell Carcinoma (Urothelial Carcinoma)Most common (90%); arises from the urothelial lining.
Squamous Cell CarcinomaAssociated with chronic bladder irritation and infections.
AdenocarcinomaRare; arises from glandular cells.

πŸ“– III. Causes / Risk Factors

  • Cigarette Smoking (Major Risk Factor).
  • Occupational Exposure to Industrial Chemicals (Aromatic Amines, Benzidine).
  • Chronic Urinary Tract Infections and Cystitis.
  • Prolonged Indwelling Catheter Use.
  • Exposure to Arsenic in Drinking Water.
  • History of Pelvic Radiation Therapy.
  • Family History of Bladder Cancer.

πŸ“– IV. Pathophysiology

  1. Carcinogens (e.g., chemicals from smoking) accumulate in urine and cause genetic mutations in urothelial cells.
  2. Leads to uncontrolled proliferation of abnormal cells, forming superficial or invasive tumors.
  3. Cancer may invade deeper layers of the bladder wall and metastasize via lymphatic and blood vessels.
  4. Common metastasis sites include pelvic lymph nodes, lungs, bones, and liver.

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • Painless Hematuria (Blood in urine)β€”Hallmark symptom.
  • Increased urinary frequency and urgency.
  • Burning sensation during urination (dysuria).
  • Pelvic or lower back pain in advanced cases.
  • Urinary retention or obstruction in severe cases.
  • Unintentional weight loss and fatigue (advanced stages).

πŸ“– VI. Diagnostic Evaluation

TestPurpose
Urine CytologyDetects malignant cells in urine.
CystoscopyDirect visualization of bladder and biopsy (Gold Standard).
CT Urography / MRIAssess tumor size, location, and spread.
Intravenous Urography (IVU)Evaluates urinary tract abnormalities.
Urine Tumor MarkersNMP22, BTA tests for monitoring.
Bone Scan / PET ScanDetect distant metastasis.

πŸ“– VII. Management

🟒 A. Preventive and Supportive Care:

  • Educate about smoking cessation.
  • Avoid exposure to industrial chemicals and occupational carcinogens.
  • Encourage adequate hydration to flush out potential toxins.
  • Early treatment of chronic UTIs and bladder irritation.

🟑 B. Treatment Modalities:

TreatmentPurpose
Transurethral Resection of Bladder Tumor (TURBT)For superficial tumors.
Intravesical TherapyBCG vaccine or chemotherapy instilled into bladder for superficial cancer.
Radical CystectomyComplete removal of bladder in advanced cases.
ChemotherapyUsed before or after surgery; Cisplatin-based regimens.
RadiotherapyInoperable tumors or palliative care.
ImmunotherapyBCG instillation stimulates local immune response.

πŸ“– VIII. Nurse’s Role in Bladder Cancer Management

  • Educate patients about early symptoms and importance of regular checkups.
  • Provide pre- and post-operative care for TURBT or cystectomy.
  • Assist in intravesical therapy procedures.
  • Monitor for complications like infection, bleeding, and urinary retention.
  • Provide care for patients with urinary diversions (ileal conduit or neobladder).
  • Offer psychological support for body image and sexual health concerns.
  • Educate about stoma care if applicable.


πŸ“š Golden One-Liners for Quick Revision:

  • Painless hematuria is the most common early sign of bladder cancer.
  • Transitional cell carcinoma is the most prevalent type.
  • Cystoscopy with biopsy is the gold standard for diagnosis.
  • Smoking is the major preventable risk factor.
  • Intravesical BCG therapy is effective for superficial bladder cancer.


βœ… Top 5 MCQs for Practice

Q1. What is the most common symptom of bladder cancer?
πŸ…°οΈ Severe abdominal pain
βœ… πŸ…±οΈ Painless hematuria
πŸ…²οΈ Persistent headache
πŸ…³οΈ Jaundice


Q2. Which test is the gold standard for diagnosing bladder cancer?
πŸ…°οΈ CT Scan
πŸ…±οΈ Urine Cytology
βœ… πŸ…²οΈ Cystoscopy with Biopsy
πŸ…³οΈ Ultrasound


Q3. Which of the following is a major risk factor for bladder cancer?
πŸ…°οΈ High calcium intake
βœ… πŸ…±οΈ Cigarette smoking
πŸ…²οΈ Low salt diet
πŸ…³οΈ Hypertension


Q4. Which therapy involves direct instillation of drugs into the bladder?
πŸ…°οΈ Oral chemotherapy
πŸ…±οΈ Intravenous chemotherapy
βœ… πŸ…²οΈ Intravesical therapy
πŸ…³οΈ Radiation therapy


Q5. Which medication is commonly used for intravesical immunotherapy in bladder cancer?
πŸ…°οΈ Methotrexate
πŸ…±οΈ Paclitaxel
βœ… πŸ…²οΈ BCG Vaccine
πŸ…³οΈ Doxorubicin

πŸ“šπŸ©Ί Gliomas (Brain Tumors)

πŸ“˜ Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

Gliomas are a group of primary brain tumors originating from the glial cells that support and protect neurons in the central nervous system (CNS). They can occur in the brain or spinal cord and are classified based on the type of glial cell involved and the tumor’s aggressiveness.

βœ… β€œGliomas are tumors derived from glial cells of the brain or spinal cord, often classified by cell type (astrocytes, oligodendrocytes, ependymal cells) and graded according to their malignancy.”


πŸ“– II. Types of Gliomas

TypeOrigin CellCommon Locations
AstrocytomasAstrocytesCerebrum, Cerebellum.
Glioblastoma Multiforme (GBM)High-grade astrocytoma (Grade IV)Cerebral hemispheres.
OligodendrogliomasOligodendrocytesFrontal lobes.
EpendymomasEpendymal cellsVentricular system, spinal cord.
Mixed GliomasMultiple glial cell typesVarious locations.

πŸ“– III. Causes / Risk Factors

  • Genetic Mutations (IDH1, IDH2, TP53).
  • Exposure to Ionizing Radiation.
  • Family History of Brain Tumors.
  • Neurofibromatosis Type 1 and 2.
  • Li-Fraumeni Syndrome.
  • Male Gender (higher incidence).
  • Age (High-grade gliomas more common after age 45).

πŸ“– IV. Pathophysiology

  1. Genetic alterations in glial cells lead to uncontrolled proliferation.
  2. Low-grade gliomas grow slowly, but high-grade tumors like Glioblastoma Multiforme (GBM) are highly invasive and rapidly growing.
  3. Tumor expansion increases intracranial pressure (ICP), compresses brain structures, and may disrupt cerebrospinal fluid (CSF) flow.
  4. Metastasis is rare outside the CNS but local invasion is aggressive.

πŸ“– V. Clinical Manifestations (Signs & Symptoms)

  • General Symptoms of Increased ICP:
    • Persistent headache (worse in the morning).
    • Nausea and vomiting.
    • Papilledema (optic disc swelling).
  • Neurological Deficits (Depending on Tumor Location):
    • Seizures.
    • Cognitive and personality changes.
    • Motor weakness or paralysis.
    • Visual disturbances (blurring, field defects).
    • Speech difficulties (aphasia).
    • Balance and coordination issues (cerebellar tumors).

πŸ“– VI. Diagnostic Evaluation

TestPurpose
MRI with ContrastGold standard for tumor visualization.
CT ScanInitial imaging in emergencies.
MR SpectroscopyDifferentiates tumor from other lesions.
Biopsy (Stereotactic or Open)Confirms histological type and grade.
Genetic TestingIDH mutation status for prognosis.
Lumbar PunctureRarely used; CSF analysis in some cases.

πŸ“– VII. Management

🟒 A. Supportive Care:

  • Control intracranial pressure with medications (e.g., Mannitol, Dexamethasone).
  • Manage seizures with antiepileptics.
  • Provide psychological support for cognitive changes.

🟑 B. Treatment Modalities:

TreatmentPurpose
Surgical ResectionCraniotomy to remove as much tumor as possible.
RadiotherapyExternal beam radiation or stereotactic radiosurgery (Gamma Knife).
ChemotherapyTemozolomide is the first-line drug for high-grade gliomas.
Targeted TherapyBevacizumab (anti-angiogenic therapy).
Palliative CareSymptom control in advanced, inoperable cases.

πŸ“– VIII. Nurse’s Role in Glioma Management

  • Monitor for neurological status changes (GCS, pupil response).
  • Administer and monitor effectiveness of anticonvulsants and corticosteroids.
  • Educate patient and family about treatment side effects.
  • Assist in post-craniotomy care (monitor for CSF leaks, infection).
  • Provide emotional support and rehabilitation guidance.
  • Assist with palliative and end-of-life care when necessary.


πŸ“š Golden One-Liners for Quick Revision:

  • Glioblastoma Multiforme (GBM) is the most aggressive form of glioma.
  • MRI with contrast is the gold standard diagnostic tool.
  • Temozolomide is the preferred chemotherapeutic agent for gliomas.
  • Bevacizumab helps reduce tumor blood supply in GBM.
  • Seizures and increased intracranial pressure are common complications.


βœ… Top 5 MCQs for Practice

Q1. What is the most aggressive type of glioma?
πŸ…°οΈ Astrocytoma
βœ… πŸ…±οΈ Glioblastoma Multiforme (GBM)
πŸ…²οΈ Oligodendroglioma
πŸ…³οΈ Ependymoma


Q2. Which imaging modality is the gold standard for diagnosing gliomas?
πŸ…°οΈ CT Scan
πŸ…±οΈ X-ray
βœ… πŸ…²οΈ MRI with Contrast
πŸ…³οΈ Ultrasound


Q3. Which chemotherapeutic agent is commonly used for high-grade gliomas?
πŸ…°οΈ Cisplatin
πŸ…±οΈ Methotrexate
βœ… πŸ…²οΈ Temozolomide
πŸ…³οΈ Vincristine


Q4. Which medication is used as a targeted therapy for glioblastoma?
πŸ…°οΈ Tamoxifen
πŸ…±οΈ Methotrexate
βœ… πŸ…²οΈ Bevacizumab
πŸ…³οΈ Leuprolide


Q5. What is a common neurological symptom associated with gliomas?
πŸ…°οΈ Hypertension
βœ… πŸ…±οΈ Seizures
πŸ…²οΈ Diarrhea
πŸ…³οΈ Jaundice

πŸ“šπŸ¦΄ Osteosarcoma

πŸ“˜ Highly Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

  • Osteosarcoma is the most common primary malignant bone tumor, arising from primitive bone-forming mesenchymal cells.
  • It typically affects children, adolescents, and young adults, commonly during growth spurts.

βœ… β€œOsteosarcoma is a high-grade malignant tumor of bone that originates from osteoblasts and produces immature bone (osteoid).”


πŸ“– II. Classification / Types

TypeDescription
Conventional OsteosarcomaMost common, aggressive; occurs in long bones.
Telangiectatic OsteosarcomaRare, resembles aneurysmal bone cyst.
Surface OsteosarcomaParosteal and periosteal types, less aggressive.
Secondary OsteosarcomaOccurs due to radiation or Paget’s disease.

πŸ“– III. Common Sites of Osteosarcoma

  • Metaphysis of long bones:
    • Distal femur
    • Proximal tibia
    • Proximal humerus

πŸ“– IV. Causes / Risk Factors

  • Rapid bone growth during adolescence
  • Previous exposure to radiation therapy
  • Genetic conditions:
    • Retinoblastoma (RB1 gene mutation)
    • Li-Fraumeni syndrome (TP53 mutation)
  • Paget’s disease of bone
  • Chronic osteomyelitis (rare)

πŸ“– V. Pathophysiology (In Brief)

  1. Malignant osteoblasts form osteoid tissue abnormally.
  2. Rapid proliferation invades surrounding bone and soft tissue.
  3. Metastasis occurs early, especially to the lungs and other bones.
  4. Tumor disrupts normal bone architecture and leads to pain, swelling, and functional loss.

πŸ“– VI. Clinical Manifestations

  • Localized bone pain, often worse at night or during activity
  • Swelling and tenderness over affected area
  • Limited range of motion in adjacent joint
  • Palpable mass or lump
  • Pathological fractures in weakened bones
  • Systemic signs (late): fever, weight loss, fatigue
  • Lung metastasis: cough, dyspnea

πŸ“– VII. Diagnostic Evaluation

  • X-ray: β€œSunburst” appearance or Codman’s triangle
  • MRI / CT Scan: Local tumor extension, soft tissue involvement
  • Bone Scan: To detect metastasis
  • Chest CT: For pulmonary metastasis
  • Biopsy: Confirm histopathological diagnosis
  • Blood Tests:
    • Elevated alkaline phosphatase
    • Elevated LDH (lactate dehydrogenase)

πŸ“– VIII. Management of Osteosarcoma

🟒 1. Medical Management

  • Neoadjuvant Chemotherapy (before surgery):
    • Drugs: Methotrexate, Doxorubicin, Cisplatin
  • Adjuvant Chemotherapy (after surgery):
    • To kill residual cancer cells and reduce recurrence

🟒 2. Surgical Management

  • Limb-Salvage Surgery: Preferred when feasible
  • Amputation: If tumor extensively invades soft tissues or neurovascular bundles
  • Rotationplasty: Functional alternative to amputation in children
  • Pulmonary Metastasectomy: For resectable lung metastasis

πŸ“– IX. Nursing Responsibilities

  • Provide preoperative and postoperative care
  • Educate patient and family about chemotherapy and its side effects
  • Monitor for signs of infection, bleeding, or wound complications
  • Support in prosthesis use and rehabilitation
  • Provide psychological support and promote body image adaptation
  • Encourage nutritional support and pain management
  • Coordinate multidisciplinary care (physiotherapist, oncologist, counselor)

πŸ“š Golden One-Liners for Quick Revision:

  • Osteosarcoma commonly affects distal femur and proximal tibia.
  • Sunburst appearance on X-ray is characteristic.
  • Lung metastasis is most common and life-threatening.
  • Neoadjuvant chemotherapy + surgery + adjuvant chemotherapy is the standard treatment.
  • Limb-sparing surgery is preferred over amputation when feasible.

βœ… Top 5 MCQs for Practice

  1. What is the most common site for osteosarcoma?
    πŸ…°οΈ Vertebrae
    πŸ…±οΈ Skull
    βœ… πŸ…²οΈ Distal femur
    πŸ…³οΈ Pelvis
  2. Which radiographic sign is typical in osteosarcoma?
    πŸ…°οΈ Onion peel appearance
    πŸ…±οΈ Ground glass opacity
    βœ… πŸ…²οΈ Sunburst appearance
    πŸ…³οΈ Soap bubble lesion
  3. Which organ is the most frequent site of metastasis in osteosarcoma?
    πŸ…°οΈ Liver
    πŸ…±οΈ Brain
    βœ… πŸ…²οΈ Lungs
    πŸ…³οΈ Intestines
  4. Which chemotherapy drug is commonly used in osteosarcoma?
    πŸ…°οΈ Vincristine
    πŸ…±οΈ Cyclophosphamide
    βœ… πŸ…²οΈ Doxorubicin
    πŸ…³οΈ Etoposide
  5. Which test is definitive for diagnosing osteosarcoma?
    πŸ…°οΈ X-ray
    πŸ…±οΈ CT scan
    πŸ…²οΈ Blood test
    βœ… πŸ…³οΈ Biopsy

πŸ“šπŸ©Ί Leukemia

πŸ“˜ Highly Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Community Health Nursing Exams


βœ… I. Introduction / Definition

  • Leukemia is a malignant disorder of the blood-forming tissues, especially the bone marrow and lymphatic system, characterized by uncontrolled proliferation of abnormal white blood cells.
  • It can be acute or chronic, and lymphocytic or myeloid in origin.

βœ… β€œLeukemia is a cancer of white blood cells characterized by excessive, abnormal proliferation of immature leukocytes in the bone marrow and blood.”


πŸ“– II. Classification / Types

TypeDescription
Acute Lymphocytic Leukemia (ALL)Rapid progression; common in children.
Acute Myeloid Leukemia (AML)Affects myeloid line; more common in adults.
Chronic Lymphocytic Leukemia (CLL)Slow progression; affects older adults.
Chronic Myeloid Leukemia (CML)Involves Philadelphia chromosome; slow progression.

πŸ“– III. Causes / Risk Factors

  • Exposure to ionizing radiation
  • Genetic predisposition (e.g., Down syndrome)
  • Certain chemotherapy drugs (alkylating agents)
  • Smoking
  • Exposure to benzene and other industrial chemicals
  • Viral infections (HTLV-1, Epstein-Barr virus)

πŸ“– IV. Pathophysiology (In Brief)

  1. Mutation in bone marrow stem cells.
  2. Abnormal WBCs multiply uncontrollably, crowding out normal cells.
  3. Decreased RBCs, platelets, and functional WBCs β†’ Anemia, bleeding, and infections.
  4. Infiltration into liver, spleen, lymph nodes, and CNS may occur.

πŸ“– V. Clinical Manifestations

  • Fatigue and weakness (due to anemia)
  • Recurrent infections (due to non-functional WBCs)
  • Bleeding tendencies (bruises, petechiae, epistaxis)
  • Fever and night sweats
  • Bone and joint pain
  • Weight loss and loss of appetite
  • Hepatosplenomegaly and lymphadenopathy
  • CNS involvement: Headache, vomiting, blurred vision (especially in ALL)

πŸ“– VI. Diagnostic Evaluation

  • Complete Blood Count (CBC): Elevated WBCs, low RBCs and platelets
  • Peripheral blood smear: Presence of immature leukemic blasts
  • Bone Marrow Aspiration and Biopsy: Definitive diagnosis
  • Immunophenotyping: To determine leukemia subtype
  • Cytogenetic analysis: Detect chromosomal abnormalities (e.g., Philadelphia chromosome in CML)
  • Lumbar puncture: To assess CNS involvement

πŸ“– VII. Management of Leukemia

🟒 1. Medical Management

  • Chemotherapy: Main treatment; includes induction, consolidation, and maintenance phases
  • Targeted Therapy: e.g., Imatinib in CML
  • Immunotherapy: Monoclonal antibodies (e.g., Rituximab)
  • Radiation Therapy: For CNS prophylaxis or localized involvement
  • Bone Marrow / Stem Cell Transplantation: For selected cases and relapses
  • Supportive Care: Blood transfusions, antibiotics, growth factors

πŸ“– VIII. Nursing Responsibilities

  • Monitor for signs of infection, bleeding, and anemia
  • Maintain strict neutropenic precautions
  • Educate on importance of oral hygiene and skin care
  • Manage chemotherapy side effects (nausea, mucositis, alopecia)
  • Monitor labs (CBC, electrolytes) and prepare for transfusions
  • Provide psychological support to patient and family
  • Educate on treatment plan and follow-up needs

πŸ“š Golden One-Liners for Quick Revision:

  • ALL is the most common leukemia in children.
  • CML is associated with the Philadelphia chromosome.
  • Bone marrow biopsy is the gold standard for diagnosis.
  • Leukemia leads to pancytopenia due to marrow suppression.
  • Neutropenic precautions are essential to prevent infection.

βœ… Top 5 MCQs for Practice

  1. Which leukemia is most common in children?
    πŸ…°οΈ AML
    πŸ…±οΈ CML
    βœ… πŸ…²οΈ ALL
    πŸ…³οΈ CLL
  2. Which chromosome is associated with CML?
    πŸ…°οΈ 21
    πŸ…±οΈ X
    βœ… πŸ…²οΈ Philadelphia chromosome (22q11)
    πŸ…³οΈ Y
  3. Which test is definitive for diagnosing leukemia?
    πŸ…°οΈ CBC
    πŸ…±οΈ Peripheral smear
    βœ… πŸ…²οΈ Bone marrow biopsy
    πŸ…³οΈ ESR
  4. Which symptom is NOT commonly associated with leukemia?
    πŸ…°οΈ Frequent infections
    βœ… πŸ…±οΈ Hypertension
    πŸ…²οΈ Anemia
    πŸ…³οΈ Bruising
  5. Which of the following is a nursing priority in a leukemic patient receiving chemotherapy?
    πŸ…°οΈ Restrict protein intake
    βœ… πŸ…±οΈ Prevent infection
    πŸ…²οΈ Encourage heavy exercise
    πŸ…³οΈ Avoid oral care

πŸ“šπŸ§¬ Lymphoma

πŸ“˜ Highly Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Medical-Surgical Nursing Exams


πŸ”° I. Definition:

Lymphoma is a malignant cancer of the lymphatic system, which includes the lymph nodes, spleen, thymus, and bone marrow.
It results from abnormal proliferation of lymphocytes, a type of white blood cell, and can affect immunity and lead to widespread organ involvement.

β€œLymphoma is a cancer that begins in the cells of the immune system (lymphocytes) and typically presents as swollen lymph nodes without pain.”


πŸ“– II. Classification / Types:

TypeDescription
Hodgkin’s Lymphoma (HL)Presence of Reed-Sternberg cells; often begins in a single lymph node group; predictable spread.
Non-Hodgkin’s Lymphoma (NHL)More common; no Reed-Sternberg cells; can involve multiple lymph nodes and extranodal sites (e.g., GI tract, CNS).

πŸ“– III. Causes / Risk Factors:

  • Infection with Epstein-Barr virus (EBV) or HIV
  • Weakened immune system (e.g., post-transplant, AIDS)
  • Exposure to pesticides, herbicides, radiation
  • Family history of lymphoma
  • Autoimmune disorders (e.g., SLE, rheumatoid arthritis)
  • Age (HL more common in 15–30 years; NHL in older adults)

πŸ“– IV. Pathophysiology (In Brief):

  1. Mutation in lymphoid stem cells (B or T lymphocytes).
  2. Uncontrolled division of abnormal lymphocytes in lymph nodes.
  3. Formation of lymphoid tumors β†’ disrupts immune function.
  4. May spread to bone marrow, spleen, liver, CNS.

πŸ“– V. Clinical Manifestations:

  • Painless swelling of lymph nodes (neck, armpits, groin)
  • Fever, night sweats, weight loss (B symptoms)
  • Fatigue, weakness
  • Itching or skin rash
  • Hepatosplenomegaly
  • Cough or chest pain (if mediastinal involvement)
  • Recurrent infections

πŸ“– VI. Diagnostic Evaluation:

  • Complete Blood Count (CBC) – May show anemia or leukocytosis
  • Lymph node biopsy – Confirms diagnosis; detects Reed-Sternberg cells (in HL)
  • Immunophenotyping – Distinguishes between HL and NHL
  • CT/MRI/PET scan – Staging and metastasis
  • Bone marrow biopsy – To assess marrow involvement
  • LDH levels – Often elevated (tumor marker)

πŸ“– VII. Management:

🟒 1. Medical Management:

  • Chemotherapy – First-line treatment (ABVD regimen for HL, CHOP for NHL)
  • Radiotherapy – For localized tumors or CNS involvement
  • Targeted Therapy – Rituximab (CD20 monoclonal antibody for B-cell NHL)
  • Stem cell/Bone marrow transplant – For relapse or aggressive forms
  • Supportive care – Blood transfusions, antibiotics, growth factors

πŸ“– VIII. Nursing Responsibilities:

  • Monitor for side effects of chemotherapy (nausea, mucositis, alopecia)
  • Implement neutropenic precautions
  • Monitor for signs of infection, bleeding, or tumor lysis syndrome
  • Educate on oral care, hygiene, hydration, and nutrition
  • Provide emotional and psychological support
  • Encourage adherence to treatment regimen and follow-ups

πŸ“š Golden One-Liners for Quick Revision:

  • Reed-Sternberg cells = Hodgkin’s lymphoma
  • NHL is more common than HL and often extranodal
  • β€œB symptoms”: Fever, night sweats, weight loss
  • Chemotherapy is the primary treatment modality
  • Rituximab is used in CD20+ B-cell NHL

βœ… Top 5 MCQs for Practice:

Q1. Which cell type is characteristic of Hodgkin’s lymphoma?
πŸ…°οΈ Plasma cells
πŸ…±οΈ Langerhans cells
βœ… πŸ…²οΈ Reed-Sternberg cells
πŸ…³οΈ Kupffer cells


Q2. β€œB symptoms” of lymphoma include all EXCEPT:
πŸ…°οΈ Weight loss
βœ… πŸ…±οΈ Constipation
πŸ…²οΈ Night sweats
πŸ…³οΈ Fever


Q3. Non-Hodgkin’s lymphoma differs from Hodgkin’s by:
πŸ…°οΈ Skin involvement
βœ… πŸ…±οΈ Absence of Reed-Sternberg cells
πŸ…²οΈ Bone-only involvement
πŸ…³οΈ Always curable


Q4. First-line treatment for lymphoma includes:
πŸ…°οΈ Surgery
βœ… πŸ…±οΈ Chemotherapy and/or radiotherapy
πŸ…²οΈ Iron therapy
πŸ…³οΈ Physical therapy


Q5. Which monoclonal antibody is used in B-cell NHL?
πŸ…°οΈ Trastuzumab
πŸ…±οΈ Bevacizumab
βœ… πŸ…²οΈ Rituximab
πŸ…³οΈ Adalimumab

πŸ“šπŸ§¬ Multiple Myeloma

πŸ“˜ Highly Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Medical-Surgical Nursing Exams


πŸ”° I. Definition:

Multiple myeloma is a malignant cancer of plasma cells (a type of white blood cell that produces antibodies), originating in the bone marrow.
It leads to the uncontrolled proliferation of abnormal plasma cells, resulting in bone destruction, anemia, immune suppression, and kidney damage.

β€œMultiple myeloma is a neoplastic proliferation of monoclonal plasma cells in bone marrow, producing abnormal immunoglobulins and causing systemic complications.”


πŸ“– II. Classification / Types:

TypeDescription
Smoldering MyelomaEarly form without symptoms; may progress
Symptomatic Multiple MyelomaActive disease with organ damage
Non-secretory MyelomaPlasma cells don’t release detectable M-protein
Light Chain Myeloma (Bence Jones myeloma)Produces only light chains; affects kidneys severely

πŸ“– III. Causes / Risk Factors:

  • Age >60 years
  • Male gender
  • African descent
  • Exposure to radiation, pesticides, or industrial chemicals (e.g., benzene)
  • Family history of myeloma or monoclonal gammopathy
  • Obesity and chronic inflammation

πŸ“– IV. Pathophysiology (In Brief):

  1. Malignant plasma cells multiply in bone marrow.
  2. These cells produce abnormal immunoglobulin (M-protein).
  3. Accumulation of plasma cells β†’ bone destruction, marrow suppression.
  4. Light chains may deposit in kidneys β†’ renal damage.
  5. Results in hypercalcemia, anemia, bone pain, infections, renal failure.

πŸ“– V. Clinical Manifestations:

  • Bone pain (especially in back, ribs, pelvis)
  • Anemia – fatigue, pallor
  • Recurrent infections (due to poor antibody production)
  • Hypercalcemia – nausea, vomiting, confusion, constipation
  • Renal failure – decreased urine output, elevated creatinine
  • Pathological fractures
  • Weight loss, weakness
  • Peripheral neuropathy in some cases

πŸ“– VI. Diagnostic Evaluation:

  • CBC: Anemia, leukopenia, thrombocytopenia
  • Serum Protein Electrophoresis (SPEP): Detects M-protein spike
  • Urine test: Bence Jones proteins in urine (light chains)
  • Bone marrow aspiration: >10% plasma cells confirms diagnosis
  • X-rays/MRI/PET: Lytic bone lesions (punched-out lesions)
  • Serum calcium: Elevated
  • Serum creatinine/BUN: Elevated in renal impairment
  • Immunofixation: Confirms monoclonal gammopathy

πŸ“– VII. Management:

🟒 1. Medical Management:

  • Chemotherapy: Bortezomib, Lenalidomide, Dexamethasone
  • Stem Cell Transplantation: Autologous transplant in fit patients
  • Bisphosphonates: To reduce bone pain and fractures
  • Corticosteroids: Reduce plasma cell burden
  • Plasmapheresis: For hyperviscosity syndrome
  • Supportive care: Analgesics, hydration, antibiotics, erythropoietin

πŸ“– VIII. Nursing Responsibilities:

  • Monitor for bone pain, fractures, renal function
  • Administer and monitor chemotherapy side effects
  • Ensure adequate hydration to prevent kidney damage
  • Monitor for hypercalcemia and signs of spinal cord compression
  • Educate on fall prevention and infection control
  • Provide psychological support due to chronic nature of disease
  • Reinforce need for routine labs and follow-ups

πŸ“š Golden One-Liners for Quick Revision:

  • Multiple myeloma = Malignant plasma cell proliferation
  • M-protein spike is diagnostic marker
  • Bence Jones proteins are found in urine
  • Common signs: Bone pain, anemia, renal failure, infections
  • Bisphosphonates help reduce skeletal complications
  • Bone marrow biopsy is confirmatory

βœ… Top 5 MCQs for Practice:

Q1. Which abnormal protein is typically found in urine in multiple myeloma?
πŸ…°οΈ Albumin
βœ… πŸ…±οΈ Bence Jones protein
πŸ…²οΈ Hemoglobin
πŸ…³οΈ Transferrin


Q2. What is the hallmark feature of bone involvement in multiple myeloma?
πŸ…°οΈ Sclerosis
πŸ…±οΈ Diffuse calcification
βœ… πŸ…²οΈ Punched-out lytic lesions
πŸ…³οΈ Osteophytes


Q3. The most common presenting symptom of multiple myeloma is:
πŸ…°οΈ Chest pain
βœ… πŸ…±οΈ Bone pain
πŸ…²οΈ Diarrhea
πŸ…³οΈ Jaundice


Q4. Which of the following is used in the treatment of multiple myeloma?
πŸ…°οΈ Metformin
πŸ…±οΈ Ciprofloxacin
βœ… πŸ…²οΈ Bortezomib
πŸ…³οΈ Omeprazole


Q5. Which test shows the β€œM-spike” in multiple myeloma?
πŸ…°οΈ CBC
πŸ…±οΈ X-ray
βœ… πŸ…²οΈ Serum protein electrophoresis
πŸ…³οΈ Creatinine test

πŸ“šπŸ§¬ Bone Marrow Transplant (BMT)

πŸ“˜ Highly Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Medical-Surgical Nursing Exams

πŸ”° I. Definition:

Bone Marrow Transplant is a medical procedure in which damaged or diseased bone marrow is replaced with healthy hematopoietic stem cells, either from the patient (autologous) or from a donor (allogeneic), to restore normal blood cell production.

“BMT is used to treat cancers like leukemia, lymphoma, and other marrow failure conditions by infusing healthy stem cells into the patient.”


πŸ“– II. Classification / Types:

TypeDescription
Autologous BMTStem cells are harvested from the patient before high-dose chemotherapy and re-infused later.
Allogeneic BMTStem cells come from a donor (matched sibling or unrelated donor).
Syngeneic BMTStem cells from an identical twin (genetically identical).
Umbilical Cord Blood TransplantStem cells are taken from umbilical cord blood after delivery.

πŸ“– III. Causes / Indications:

  • Leukemia (ALL, AML, CML, CLL)
  • Lymphoma (Hodgkin’s, Non-Hodgkin’s)
  • Multiple Myeloma
  • Aplastic Anemia
  • Thalassemia Major
  • Sickle Cell Anemia
  • Severe Combined Immunodeficiency (SCID)
  • Bone marrow failure syndromes

πŸ“– IV. Pathophysiology (In Brief):

  1. Bone marrow becomes damaged/diseased due to cancer, chemotherapy, or genetic disorders.
  2. Abnormal or deficient stem cells fail to produce healthy blood cells.
  3. Transplantation of healthy hematopoietic stem cells restores RBC, WBC, and platelet production.
  4. The new marrow engrafts and begins producing healthy cells.

πŸ“– V. Clinical Manifestations (Post-BMT Complications):

  • Fever, chills (sign of infection)
  • Mucositis (mouth sores)
  • Bleeding, bruising (due to thrombocytopenia)
  • Graft-versus-host disease (GVHD) in allogeneic BMT
  • Fatigue, anorexia
  • Immunosuppression β†’ high risk of infections
  • Engraftment syndrome

πŸ“– VI. Diagnostic Evaluation:

  • CBC and differential count
  • Bone marrow biopsy (pre-transplant evaluation)
  • HLA typing (for donor compatibility)
  • Liver and kidney function tests
  • Viral screening (HIV, Hepatitis B/C, CMV)
  • Chest X-ray & ECG (pre-transplant assessment)

πŸ“– VII. Management:

🟒 1. Pre-Transplant Phase:

  • Patient receives conditioning regimen (high-dose chemotherapy Β± radiation) to destroy diseased marrow.

🟒 2. Transplantation Phase:

  • Infusion of harvested stem cells via IV like a blood transfusion.

🟒 3. Post-Transplant Phase:

  • Monitor for engraftment, infections, and GVHD
  • Use of growth factors (G-CSF) to stimulate cell recovery
  • Long-term immunosuppressants in allogeneic transplants

πŸ“– VIII. Nursing Responsibilities:

  • Maintain strict aseptic precautions (neutropenic care)
  • Monitor for signs of GVHD (rash, diarrhea, liver enzymes)
  • Administer immunosuppressants and antibiotics as prescribed
  • Ensure nutritional support and hydration
  • Provide oral care to prevent mucositis
  • Educate patient and family about:
    • Infection prevention
    • Long-term follow-up
    • Medication compliance

πŸ“š Golden One-Liners for Quick Revision:

  • BMT replaces damaged bone marrow with healthy stem cells
  • Autologous BMT uses patient’s own cells
  • Allogeneic BMT carries risk of GVHD
  • HLA matching is critical for donor compatibility
  • Nurses play a key role in infection control and patient education

βœ… Top 5 MCQs for Practice:

Q1. Which type of bone marrow transplant uses the patient’s own stem cells?
πŸ…°οΈ Allogeneic
βœ… πŸ…±οΈ Autologous
πŸ…²οΈ Syngeneic
πŸ…³οΈ Cord blood


Q2. A major complication of allogeneic BMT is:
πŸ…°οΈ Anemia
πŸ…±οΈ Mucositis
βœ… πŸ…²οΈ Graft-versus-host disease
πŸ…³οΈ Constipation


Q3. Bone marrow transplant is commonly used in which condition?
πŸ…°οΈ Osteoarthritis
πŸ…±οΈ Tuberculosis
βœ… πŸ…²οΈ Leukemia
πŸ…³οΈ Myopia


Q4. Which test is done to ensure donor compatibility in BMT?
πŸ…°οΈ ABO blood grouping
βœ… πŸ…±οΈ HLA typing
πŸ…²οΈ ESR
πŸ…³οΈ Mantoux test


Q5. The primary nursing goal after BMT is to:
πŸ…°οΈ Encourage exercise
πŸ…±οΈ Limit fluid intake
βœ… πŸ…²οΈ Prevent infections
πŸ…³οΈ Stop immunosuppressants

πŸ“šπŸš¨ Oncological Emergencies

πŸ“˜ Highly Important for GNM/BSc Nursing, NHM, AIIMS, NORCET, GPSC & Medical-Surgical Nursing Exams


  Definition:

Oncological emergencies are acute, life-threatening complications arising either due to cancer itself or its treatment.
They may be metabolic, hematologic, or structural, and require immediate recognition and intervention to prevent morbidity or death.

“Oncological emergencies are urgent conditions in cancer patients requiring rapid diagnosis and treatment to avoid severe complications or death.”

πŸ“šπŸ« Superior Vena Cava Syndrome (SVCS)

πŸ”° I. Definition:

Superior Vena Cava Syndrome (SVCS) is a medical emergency caused by obstruction or compression of the superior vena cava, leading to impaired venous drainage from the head, neck, upper chest, and upper limbs, resulting in venous congestion and edema.

β€œSVCS is the clinical manifestation of impaired blood flow through the superior vena cava due to tumor compression, thrombosis, or fibrosis.”


πŸ“– II. Classification / Types:

TypeDescription
Malignant SVCSCaused by cancers (e.g., lung cancer, lymphoma, metastases) β€” most common
Non-malignant SVCSCaused by thrombosis (e.g., central venous catheters, pacemakers), infections, or mediastinal fibrosis

πŸ“– III. Causes / Risk Factors:

  • Bronchogenic carcinoma (especially small cell lung cancer)
  • Non-Hodgkin’s lymphoma / Hodgkin’s disease
  • Metastatic tumors in mediastinum
  • Thrombosis from central venous catheters or pacemakers
  • Tuberculosis / fungal infections (mediastinal fibrosis)
  • Previous chest radiation therapy

πŸ“– IV. Pathophysiology (In Brief):

  1. Obstruction or compression of the superior vena cava (SVC) occurs.
  2. Leads to impaired venous return from head, neck, and upper extremities.
  3. Causes venous congestion, increased capillary pressure β†’ edema, cyanosis, and collateral vein formation.
  4. Can cause airway compromise and cerebral edema in severe cases.

πŸ“– V. Clinical Manifestations:

  • Swelling of face, neck, arms, and upper chest
  • Dilated neck and chest veins
  • Dyspnea, cough, hoarseness
  • Cyanosis of lips or face
  • Headache, dizziness, confusion (due to cerebral edema)
  • Stridor or orthopnea (airway compression)
  • Visual disturbances

πŸ“– VI. Diagnostic Evaluation:

  • Chest X-ray – Mediastinal widening, mass
  • CT Scan with contrast – Identifies cause, location, and severity
  • MRI – For soft tissue assessment
  • Venography – For vascular evaluation
  • Biopsy – Of tumor or lymph node (if malignancy suspected)
  • Doppler ultrasound – If thrombosis is suspected in SVC or subclavian vein

πŸ“– VII. Management:

🟒 1. Immediate Symptom Relief:

  • Elevate head of bed (↑ venous return)
  • Oxygen therapy
  • Diuretics to reduce edema
  • Steroids (e.g., dexamethasone) to reduce inflammation and tumor swelling

🟒 2. Definitive Treatment:

  • Radiotherapy – For radiosensitive tumors (e.g., lymphoma)
  • Chemotherapy – In lung cancers, lymphomas
  • Anticoagulation or thrombolysis – If due to thrombus
  • Stent placement (endovascular) – For quick relief in severe SVCS
  • Surgery – Rare; for tumor resection or bypass graft

πŸ“– VIII. Nursing Responsibilities:

  • Assess for signs of respiratory distress or airway obstruction
  • Position patient upright (semi-Fowler’s) to reduce pressure
  • Administer oxygen, corticosteroids, and diuretics as prescribed
  • Monitor vital signs, neurological status, and fluid balance
  • Provide a calm environment to reduce anxiety
  • Prepare for emergency airway management if needed
  • Educate patient on avoiding tight clothing/jewelry around the neck or chest

πŸ“š Golden One-Liners for Quick Revision:

  • SVCS = obstruction of superior vena cava β†’ venous congestion of upper body
  • Most common cause = lung cancer
  • Facial swelling and dyspnea are hallmark signs
  • CT chest is best for diagnosis
  • Treatment includes steroids, chemotherapy, radiotherapy, and stenting
  • Airway and cerebral edema are life-threatening complications

βœ… Top 5 MCQs for Practice:

Q1. The most common cause of SVCS is:
πŸ…°οΈ Heart failure
πŸ…±οΈ Tuberculosis
βœ… πŸ…²οΈ Lung cancer
πŸ…³οΈ Renal failure


Q2. A classic clinical sign of SVCS is:
πŸ…°οΈ Edema in lower limbs
πŸ…±οΈ Jaundice
βœ… πŸ…²οΈ Swelling of face and neck
πŸ…³οΈ Diarrhea


Q3. Which diagnostic tool is most definitive for SVCS?
πŸ…°οΈ ECG
πŸ…±οΈ Ultrasound abdomen
βœ… πŸ…²οΈ Contrast-enhanced CT chest
πŸ…³οΈ Urine routine test


Q4. What is the initial nursing action in SVCS?
πŸ…°οΈ Lie the patient flat
βœ… πŸ…±οΈ Elevate the head of bed
πŸ…²οΈ Administer iron supplements
πŸ…³οΈ Encourage ambulation


Q5. Which of the following drugs is commonly used in SVCS to reduce tumor swelling?
πŸ…°οΈ Metformin
πŸ…±οΈ Paracetamol
βœ… πŸ…²οΈ Dexamethasone
πŸ…³οΈ Amoxicillin

πŸ“šπŸ’₯ Tumor Lysis Syndrome (TLS)

πŸ”° I. Definition:

Tumor Lysis Syndrome (TLS) is a life-threatening oncologic emergency that occurs when a large number of cancer cells are destroyed rapidly, releasing their intracellular contents (potassium, phosphate, nucleic acids) into the bloodstream, leading to electrolyte imbalances and acute renal failure.

β€œTLS is a metabolic emergency resulting from massive tumor cell breakdown, most often after chemotherapy in high-grade malignancies.”


πŸ“– II. Classification / Types:

TypeDescription
Spontaneous TLSOccurs without treatment in highly proliferative tumors
Therapy-Induced TLSOccurs after chemotherapy or radiotherapy, most common form

πŸ“– III. Causes / Risk Factors:

  • High-grade lymphomas (e.g., Burkitt’s lymphoma)
  • Acute leukemias (especially ALL, AML)
  • Large tumor burden
  • High sensitivity to chemotherapy
  • Pre-existing renal impairment
  • Inadequate hydration during treatment

πŸ“– IV. Pathophysiology (In Brief):

  1. Rapid tumor cell lysis releases intracellular contents.
  2. Leads to:
    1. Hyperkalemia β†’ arrhythmias
    1. Hyperphosphatemia β†’ secondary hypocalcemia
    1. Hyperuricemia β†’ uric acid crystal deposition
  3. Results in acute kidney injury, cardiac, and neuromuscular symptoms.

πŸ“– V. Clinical Manifestations:

  • Nausea, vomiting, diarrhea
  • Muscle cramps, tetany, seizures (due to hypocalcemia)
  • Lethargy, confusion
  • Oliguria or anuria (due to uric acid nephropathy)
  • Cardiac arrhythmias
  • Sudden death if untreated

πŸ“– VI. Diagnostic Evaluation:

  • Serum electrolytes: ↑ Potassium, phosphate, uric acid; ↓ Calcium
  • Serum creatinine, BUN: ↑ (renal dysfunction)
  • Urinalysis: Crystals, hematuria
  • ECG: Arrhythmias, tall peaked T-waves (hyperkalemia)
  • TLS Diagnosis Criteria (Cairo-Bishop): Based on lab & clinical parameters

πŸ“– VII. Management:

🟒 1. Prevention:

  • Aggressive IV hydration before and during chemotherapy
  • Allopurinol – Prevents uric acid formation
  • Rasburicase – Breaks down existing uric acid
  • Monitor labs every 4–6 hours during high-risk treatment

🟒 2. Acute Management:

  • Correct electrolyte imbalances:
    • Calcium gluconate (for hypocalcemia symptoms)
    • Insulin + glucose (for hyperkalemia)
  • Dialysis: In case of refractory hyperkalemia or renal failure
  • Continue hydration and urine alkalinization (in some cases)

πŸ“– VIII. Nursing Responsibilities:

  • Identify high-risk patients (e.g., hematologic cancers with high tumor burden)
  • Monitor electrolytes, fluid balance, ECG
  • Administer allopurinol or rasburicase as prescribed
  • Ensure adequate hydration and strict I/O charting
  • Educate patient and family on warning signs
  • Be prepared for emergency interventions (e.g., seizure, cardiac arrest)

πŸ“š Golden One-Liners for Quick Revision:

  • TLS = Rapid tumor breakdown β†’ electrolyte imbalance
  • Common in acute leukemias and high-grade lymphomas
  • Hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia = hallmark signs
  • Preventable with hydration, allopurinol, rasburicase
  • Dialysis may be required in severe renal failure

βœ… Top 5 MCQs for Practice:

Q1. Tumor Lysis Syndrome is most commonly associated with:
πŸ…°οΈ Breast cancer
βœ… πŸ…±οΈ Acute leukemias and lymphomas
πŸ…²οΈ Carcinoma of cervix
πŸ…³οΈ Basal cell carcinoma


Q2. Which electrolyte abnormality is NOT typically seen in TLS?
πŸ…°οΈ Hyperkalemia
πŸ…±οΈ Hyperuricemia
βœ… πŸ…²οΈ Hypercalcemia
πŸ…³οΈ Hyperphosphatemia


Q3. A drug used to prevent uric acid formation in TLS is:
πŸ…°οΈ Furosemide
πŸ…±οΈ Calcium gluconate
βœ… πŸ…²οΈ Allopurinol
πŸ…³οΈ Heparin


Q4. A life-threatening complication of TLS is:
πŸ…°οΈ Hypertension
πŸ…±οΈ Hyperglycemia
βœ… πŸ…²οΈ Acute kidney failure
πŸ…³οΈ Bradycardia


Q5. Which of the following is a nursing priority in TLS?
πŸ…°οΈ Ambulation
βœ… πŸ…±οΈ Monitor electrolyte levels and renal function
πŸ…²οΈ Fluid restriction
πŸ…³οΈ High-protein diet

πŸ“šπŸ§  Spinal Cord Compression (SCC)

πŸ”° I. Definition:

Spinal Cord Compression (SCC) is an oncological emergency that occurs when a tumor or lesion compresses the spinal cord or its blood supply, leading to neurological deficits such as pain, paralysis, and loss of bladder or bowel control.

β€œSCC is a condition where the spinal cord is compressed by a tumor, abscess, or vertebral collapse, causing progressive neurological dysfunction.”


πŸ“– II. Classification / Types:

TypeDescription
Malignant SCCCaused by tumor metastasis (most common)
Non-malignant SCCCaused by infections (abscess), herniated discs, trauma
Acute SCCRapid onset; requires immediate intervention
Chronic SCCGradual progression of symptoms over weeks/months

πŸ“– III. Causes / Risk Factors:

  • Metastatic cancers (breast, lung, prostate, multiple myeloma)
  • Primary spinal tumors (rare)
  • Infectious causes (e.g., tuberculosis, epidural abscess)
  • Vertebral fractures or trauma
  • Post-radiation fibrosis or scarring

πŸ“– IV. Pathophysiology (In Brief):

  1. Tumor/inflammation/fracture compresses the spinal cord or blood vessels.
  2. Leads to decreased blood flow, ischemia, and nerve damage.
  3. Results in sensory and motor loss, bladder/bowel dysfunction, and paralysis if untreated.

πŸ“– V. Clinical Manifestations:

  • Back pain (early and most common symptom)
  • Radicular pain (shooting pain along nerve distribution)
  • Motor weakness (limbs)
  • Sensory loss (numbness, tingling)
  • Paralysis (if not treated)
  • Loss of bladder or bowel control
  • Gait disturbance, spasticity
  • Increased deep tendon reflexes

πŸ“– VI. Diagnostic Evaluation:

  • MRI spine: Gold standard for diagnosis
  • CT scan: For bony detail (e.g., vertebral collapse)
  • X-ray spine: May show vertebral metastasis
  • Bone scan: Detects metastatic spread
  • Neurological assessment: Reflexes, sensation, motor function
  • Blood tests: CBC, ESR, tumor markers (if malignancy suspected)

πŸ“– VII. Management:

🟒 1. Medical Management:

  • High-dose corticosteroids (e.g., dexamethasone) – Reduce inflammation & edema
  • Radiation therapy – For radiosensitive tumors (e.g., lymphoma)
  • Chemotherapy – In systemic malignancy causing SCC
  • Pain management – Opioids, NSAIDs

🟒 2. Surgical Management:

  • Decompression laminectomy – To remove tumor or relieve pressure
  • Spinal stabilization – For structural support

πŸ“– VIII. Nursing Responsibilities:

  • Perform frequent neurological assessments
  • Monitor pain, reflexes, muscle strength, bladder/bowel function
  • Administer steroids and pain relief as prescribed
  • Educate on log-rolling technique and spinal precautions
  • Assist with mobility aids and fall prevention
  • Provide emotional support for sudden functional loss
  • Prepare patient and family for rehabilitation planning

πŸ“š Golden One-Liners for Quick Revision:

  • SCC is an oncologic emergency causing neurologic impairment
  • Most common presenting symptom = back pain
  • SCC is commonly due to metastatic tumors (breast, lung, prostate)
  • MRI is the investigation of choice
  • Treated with steroids, radiotherapy, or surgical decompression

βœ… Top 5 MCQs for Practice:

Q1. The most common cause of spinal cord compression in adults is:
πŸ…°οΈ Trauma
βœ… πŸ…±οΈ Metastatic cancer
πŸ…²οΈ Tuberculosis
πŸ…³οΈ Herniated disc


Q2. The earliest and most common symptom of SCC is:
πŸ…°οΈ Paralysis
πŸ…±οΈ Incontinence
βœ… πŸ…²οΈ Back pain
πŸ…³οΈ Fever


Q3. The gold standard diagnostic tool for SCC is:
πŸ…°οΈ X-ray
πŸ…±οΈ CT scan
βœ… πŸ…²οΈ MRI
πŸ…³οΈ PET scan


Q4. First-line drug used to reduce edema in SCC is:
πŸ…°οΈ Paracetamol
πŸ…±οΈ Morphine
βœ… πŸ…²οΈ Dexamethasone
πŸ…³οΈ Diazepam


Q5. A nursing priority in managing SCC is:
πŸ…°οΈ Encourage fluid restriction
βœ… πŸ…±οΈ Monitor neurologic status and prevent falls
πŸ…²οΈ Restrict movement completely
πŸ…³οΈ Start high-protein diet immediately

πŸ“šπŸ§ͺ Hypercalcemia of Malignancy

πŸ”° I. Definition:

Hypercalcemia of malignancy is an oncologic metabolic emergency caused by elevated levels of calcium in the blood, usually due to cancer-related factors, and leads to neurological, renal, and gastrointestinal complications.

β€œHypercalcemia is defined as a serum calcium level >10.5 mg/dL and becomes life-threatening at levels >14 mg/dL.”


πŸ“– II. Classification / Types:

TypeMechanism
Humoral HypercalcemiaMost common; due to secretion of parathyroid hormone-related protein (PTHrP) by tumors
Local Osteolytic HypercalcemiaFrom direct bone destruction by metastases (e.g., multiple myeloma, breast cancer)
Vitamin D-mediatedSeen in lymphomas causing increased vitamin D levels
Ectopic PTH secretionRare; tumors produce actual parathyroid hormone

πŸ“– III. Causes / Risk Factors:

  • Breast cancer
  • Lung cancer (especially squamous cell carcinoma)
  • Multiple myeloma
  • Lymphomas
  • Prolonged immobility in cancer patients
  • Bone metastasis
  • Dehydration, thiazide diuretics

πŸ“– IV. Pathophysiology (In Brief):

  1. Tumors secrete PTHrP or cause bone destruction.
  2. Leads to release of calcium from bones and increased renal calcium reabsorption.
  3. Results in elevated serum calcium β†’ affects muscles, kidneys, brain, and heart.

πŸ“– V. Clinical Manifestations:

  • Neurological: Confusion, fatigue, lethargy, coma
  • GI: Nausea, vomiting, constipation, anorexia
  • Renal: Polyuria, polydipsia, dehydration, renal failure
  • Musculoskeletal: Bone pain, muscle weakness
  • Cardiac: Bradycardia, shortened QT interval, arrhythmias
  • Psychiatric: Depression, anxiety, irritability

πŸ“– VI. Diagnostic Evaluation:

  • Serum total calcium: >10.5 mg/dL
  • Ionized calcium: Most accurate form of calcium
  • PTH: Suppressed in malignancy-related hypercalcemia
  • PTHrP: Elevated in humoral hypercalcemia
  • Serum creatinine/BUN: Evaluate renal function
  • ECG: Short QT interval, possible arrhythmias

πŸ“– VII. Management:

🟒 1. Immediate Interventions:

  • IV hydration with normal saline (first-line)
  • Loop diuretics (e.g., furosemide) to promote calcium excretion
  • Bisphosphonates (e.g., zoledronic acid, pamidronate) – inhibit bone resorption
  • Calcitonin – quick but short-acting calcium-lowering agent
  • Dialysis – in patients with severe renal failure or refractory hypercalcemia

🟒 2. Long-Term Management:

  • Treat the underlying malignancy (chemotherapy, radiotherapy)
  • Discontinue calcium-raising medications

πŸ“– VIII. Nursing Responsibilities:

  • Monitor serum calcium, ECG, I/O, mental status
  • Ensure adequate hydration and IV fluid administration
  • Administer prescribed bisphosphonates or calcitonin
  • Assess for muscle weakness, lethargy, constipation
  • Provide safety measures for confused or lethargic patients
  • Educate on symptom recognition and medication compliance

πŸ“š Golden One-Liners for Quick Revision:

  • Calcium >10.5 mg/dL = hypercalcemia
  • Most common cause in cancer = PTHrP secretion or bone metastasis
  • Classic symptoms = β€œStones, Bones, Groans, Moans”
  • First-line treatment = IV fluids + loop diuretics
  • Bisphosphonates are drug of choice in malignancy-related hypercalcemia

βœ… Top 5 MCQs for Practice:

Q1. What is the normal upper limit of serum calcium?
πŸ…°οΈ 8.5 mg/dL
πŸ…±οΈ 9.5 mg/dL
βœ… πŸ…²οΈ 10.5 mg/dL
πŸ…³οΈ 11.5 mg/dL


Q2. Which cancer is most commonly associated with hypercalcemia?
πŸ…°οΈ Colon cancer
βœ… πŸ…±οΈ Lung cancer (especially squamous cell type)
πŸ…²οΈ Thyroid cancer
πŸ…³οΈ Skin cancer


Q3. Which medication is used to reduce bone resorption in hypercalcemia?
πŸ…°οΈ Prednisolone
βœ… πŸ…±οΈ Zoledronic acid
πŸ…²οΈ Digoxin
πŸ…³οΈ Metformin


Q4. Which ECG change is seen in hypercalcemia?
πŸ…°οΈ Prolonged QT interval
βœ… πŸ…±οΈ Shortened QT interval
πŸ…²οΈ ST elevation
πŸ…³οΈ T wave inversion


Q5. A nursing priority in managing a patient with hypercalcemia includes:
πŸ…°οΈ Restricting fluids
πŸ…±οΈ Encouraging bedrest
βœ… πŸ…²οΈ Ensuring adequate IV hydration and monitoring ECG
πŸ…³οΈ Giving calcium supplements

Published
Categorized as MSN-PHC-SYNP, Uncategorised